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Cardioplegic solutions are used to arrest and preserve hearts 
during cardiac bypass and donor heart storage for 
transplantation. Optimal efficacy of these solutions is 
required to ensure maximum recovery of the hearts. 
The st Thomas' Hospital cardioplegic solution No 2 (ST) is a 
basic crystalloid solution with an electrolyte composition 
similar to blood, but with a high potassium concentration 
(16 mmol/1) to induce arrest. The addition of glucose to this 
solution to provide anaerobic energy has been disputed. Using 
the isolated perfused rat heart model, the inclusion of 
11 mmol/1 glucose in the cardioplegic solution was tested with 
an arrest period of three hours at 10°c. With an initial bolus 
of 10 ml of cardioplegia (single dose), followed by 
uninterrupted arrest, percentage recoveries of aortic output 
indicated little 6r no effect with the addition of glucose. 
Aortic output recovery with ST was 57.4 ± 5.2 % (mean± sem) 
while with glucose (ST+G) the recovery was 65.9 ± 2.9 %. 
However, with multidose infusions of cardioplegic solution 
(6 ml every 30 minutes), recoveries increased to 74.6 ± 1.9 % 
(ST) (p<0.05) and 87.4 ± 1.9 % (ST+G) (p<0.05). The use of 
multidose cardioplegia proved to be beneficial, possibly 
because of washout of harmful end products of glycolysis and 
protons. The presence of glucose in this protocol was 
additionally advantageous (multidose ST vs ST+G - p<0.05), by 
providing essential anaerobic ATP. 
The question arose as to whether oxygen is 
arrested hearts, and what the optimal 
cardioplegic solution. This was tested 
beneficial to the 
pH is for the 
with the ST+G 
cardioplegic solution used in the above mul tidose protocol. 
The cardioplegic solution was gassed either with 100% N2 
(anoxic, alkaline - pH 9), 100% o 2 (oxygenated, alkaline - pH 
9), 95%N2 5%co2 ( anoxic, acidotic - pH 7), or 95%02 5%co2 
(oxygenated, acidotic - pH 7) . In alkaline cardioplegia the 
aortic output recovery was improved from 52.3 ± 2.7% (100% N2 ) 
to 66.3 ± 2.8 % (100% o 2 ) (p<0.05) with oxygenation. In 
ii 
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acidotic cardioplegia, oxygenation again proved beneficial 
with recoveries of aortic output of 88.9 ± 3.7 % (95%0 2 5%C0 2) 
compared to 63.9 ± 2.8 % (95%N2 5%co2 ) (p<0.05). When 
comparing the respective anoxic and 
acidotic cardioplegia proved to be more 
oxygenated groups, 
beneficial ( p<O. 05). 
The optimal results were obtained by oxygenation at a low pH 
( 95%0 2 5%C0 2 ) . Oxygenation switches the production of energy 
from glycolysis to oxidative phosphorylation, a far more 
efficient process. A low pH is thought to protect the heart 
against the entry of calcium. 
These results were obtained using a multi dose protocol model 
which can only be applied with cardiac bypass. With long term 
storage of donor hearts for transplantation, the use of an 
initial bolus of solution only is practical. The accumulated 
metabolites are therefore not washed out and must be dealt 
with in an alternative manner. Using the ST+G cardioplegia, we 
tested the effect of an increased buffering capacity by the 
addition of 50 mmol/1 histidine. This may be especially 
beneficial in the presence of glucose, as enhanced glycolysis 
is associated with greater proton production. Osmotic space 
was made available by a reduction of 20 mmol/1 in the NaCl 
concentration. As a control, sucrose (a non-metabolisable 
sugar) was added instead of histidine. There were no 
significant differences in the aortic recoveries of the 
control groups ( ST+G - 61. O ± 2 .1 % ; ST+G+sucrose - 57. 2 ± 
2. 4%). However, with the addition of histidine, recoveries 
increased significantly (76.1 ± 3.4 %) (p<0.05 vs control 
groups). A higher concentration of histidine was tested 
( 80 mmol/1) but this was found to reduce recoveries ( 54. 7 ± 
3.3 %). The increased buffering capacity was thought to 
prevent the large decrease in pH associated with ischaemia, 
and thereby protect the myocardium. 
Conclusions 
Although the rat and the human myocardium show distinct 
differences, various conclusions can be drawn from this work 
1) 11 mmol/1 glucose was advantageous in a multidose protocol 
2) In a multidose protocol, the glucose-containing St Thomas' 
Hospital No 2 cardioplegic solution should be gassed with 
95%02 5%C02 . 












and multi dose 
These alterations must be further tested on a larger animal 
model before being used on human patients. 
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I. AIMS AND HYPOTHESIS 
The aim of this investigation was to improve on the 
formulation of a cardioplegic solution used in cardio-
pulmonary bypass operations, thereby improving the recovery of 
arrested hearts. In extension, we wished to be able to prolong 
the duration of storage of donor hearts for transplantation, 
to enable long distance procurement of such hearts. 
A cardioplegic solution must be adequately tested in the 
laboratory before being used clinically. We chose to evaluate 
alterations to the basic St Thomas' Hospital crystalloid 
cardioplegic solution No 2 ( ST) ( see Table 1). This 1s an 
internationally recognised solution formulated by David Hearse 
and colleagues ( Hearse et al. , 1981) which has been in use 
since 1981. Its ionic composition is similar to that of blood, 
with a high potassium concentration as the cardioplegic agent. 
Much research has been done on cardioplegic solutions in 
recent years, with many varying reports as to the efficacies 
of different formulations. Many assumptions have been made 
using results which cannot be directly extrapolated to one's 
own model. Variations in ionic composition, temperature, 
substrate availability, number of administrations of solution, 
time of arrest, 
the literature 
addition of a 
and species differences lead to confusion in 
as to an optimal formulation. While the 
specific agent may be efficacious in one 
formulation, in another formulation with a different ionic 
composition and method of usage, the same agent may prove 
deleterious. We wished to follow a logical approach based on 
the principle of enhanced energy production by glycolysis and 
oxidative phosphorylation, taking into account the changes 
which occur during an ischaemic period. 
The isolated working rat heart model (the Langendorff 
apparatus (1895) modified by Neely et al., 1967) was used to 
test the effects of modifications to this solution on the 
functional recovery of the hearts after an extended period of 
arrest. Protocols approximating both cardio-pulmonary bypass 
(intermittent flushing with cardioplegic solution - multidose) 
1 
2 
and donor heart storage (initial dose of cardioplegic solution 
followed by simple storage - single dose) were used. 
1) The inclusion of glucose in the ST was tested, as 
glycolytic ATP has been shown to be important to the ischaemic 
myocardium. The increased production of high energy phosphates 
with the addition of this energy substrate may improve 
recoveries. 
2) The use of single dose and multidose protocols of 
administration of cardioplegic solution with and without 
glucose was compared, as glucose is thought to lead to the 
production of metabolites which may be harmful to the arrested 
heart if these accumulate. If, however, these are washed out 
by intermittent flushing with cardioplegic solution, this may 
be beneficial to the hearts. 
3) Using a multidose protocol, which approximates to the 
clinical cardio-pulmonary bypass, we tested whether the 
presence of oxygen· in the ST+Glucose cardioplegic solution was 
required in the presence of glucose, as this converts the 
usage of glucose from glycolysis to oxidative phosphorylation, 
a much more efficient pathway. 
4) With oxygenation of a solution, the pH is altered. We 
tested whether a high or a low pH was more beneficial in the 
presence of oxygen in the ST+Glucose cardioplegic solution 
used in a mul tidose protocol. A low pH is thought to be 
protective during ischaemia, but with long term arrest, 
intracellular pH may decline to levels resulting in injury to 
the myocytes. 
5) Using a single dose protocol of administration of 
cardioplegic solution, gassing of the solution is a relatively 
short term effect. As we wished to be able to extend the 
duration of arrest of donor hearts, we tested a more longterm 
alteration to the ST+Glucose solution, with the addition of 
histidine as a buffer to combat the increased proton 
production associated with the presence of glucose. 
3 
Table 1: Ionic composition (mmol/1) of modified Krebs-
Henseleit buffer (K-H - pH given when gassed with 95%0 2 5%co 2 
as is normally done during perfusions) and St Thomas' Hospital 
cardioplegic solution No 1 ( ST Nol) and No 2 ( ST No2) ( from 
Ledingham et al., 1987 ungassed solutions), with 
intracellular (IC) and extracellular (EC) values (from Opie, 
1984) (In brackets - free ionised concentrations) (Osmolality 
- measured) . 
IC EC K-H ST Nol ST No2 
Na+ 5-12 ( 6) 120-145 143 144 120 
K+ 110-140 (80) 5 5 20 16 
Mg2+ 15-17 ( 0 . 7 ) 1. 2 (0.6) 1. 2 16 16 
ca 2+ 1-2 (<10- 6 ) 2.5 (1.25) 1. 25 2.2 1.2 
Cl- 30 110-140 123 183 160 
PO 2-4 80 5 1.2 
HCO -3 8-10 24-31 25 10 
so 4 




pH 7.4 7.4 7.4 5.5-7.0 7.8 
(37°C) 
Osmolality 
(mOsm/ ) 282 282 290 300-320 285-300 
kg H20) 
II. BACKGROUND 
i) Definition of cardioplegia 
Cardioplegia - Paralysis of the heart. This, the dictionary 
definition, indicates the original aim of cardioplegia; to 
arrest the heart and prevent electromechanical activity. 
Arrest of the heart is required to allow surgery to be carried 
out in a bloodless field in the absence of mechanical 
movement. 
However, an arrested heart is also made ischaemic, which is 
associated with myocardial damage and poor recovery on 
reperfusion. The more modern approach for a cardioplegic 
solution therefore places greater emphasis on maintenance of 
the integrity of the heart, or "myocardial preservation" 
(Bretschneider, 1980), during arrest, thereby ensuring maximal 
recovery upon reperfusion. 
4 
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ii) Approaches to the development of a cardioplegic solution -
historical review 
There are many formulations of cardioplegic solutions which 
have been tested using different animal models, and different 
protocols of administration. 
Melrose et al. (1955) introduced the concept of "elective 
cardiac arrest", using a solution of blood containing a high 
concentration of potassium citrate (2.5%). However, this 
proved to be deleterious to the myocardium (see Hearse et al., 
1981) and the use of cardioplegic solutions was largely 
ignored in preference to other means of arrest, such as 
coronary perfusion and topical hypothermia. However, 
Bretschneider and others in Germany continued research in this 
field and developed the so-called "intracellular" cardioplegic 
solutions during the 1960's (see Bretschneider et al., 1975). 
The principle was to induce arrest by reducing the sodium and 
calcium concentrations, in an effort to inhibit the 
development of an ionic gradient across the membrane. This 
inhibits the expenditure of energy by decreasing 
electrophysiological and contractile activity. 
In 1976, Hearse et al. published a study using the working rat 
heart model in which they tested various components of 
cardioplegic solutions previously used. A solution based on 
the Krebs-Henseleit buffer (see Table 1), with 12 mmol/1 
potassium, 16 mmol/1 magnesium, 10 mmol/1 adenosine 
triphosphate, 10 mmol/1 creatine phosphate, and 1 mmol/1 
procaine, to be used at a temperature of about Jo 0 c, was 
formulated. The ionic composition of this first "St Thomas' 
Hospital cardioplegic solution" was therefore based on the 
ionic composition of blood, that is, a so-called 
"extracellular" solution. Over the following years the St 
Thomas' Hospital No 1 solution was fully tested and developed 
further (Hearse et al., 1978a; 1978b; Hearse et al., 1981) 
(see Table 1). This solution was used until 1981, when further 
alterations, with a control for pH with the inclusion of 
bicarbonate as a buffer, and reduced sodium for osmotic spac~,-
were made. This was called the St Thomas' Hospital No 2 
solution (see Table 1), which has been found to be far better 
than the No 1 solution (Ledingham et al., 1987). 
Buckberg reintroduced the concept of blood-based cardioplegic 
solutions in 1979, which may have many advantages over 
crystalloid solutions as there are many intrinsic substances 
of use to the arrested heart. There is an oxygen carrying 
vehicle (haemoglobin) which can also carry co2 , good buffers 
(histidine, bicarbonate, phosphates), substrates, and the 
correct ionic composition (Ledingham et al., 1988). However, 
there are disadvantages associated with a blood based 
solution, including increasing viscosity at lower 
temperatures, which may block the vascular bed and prevent 




a) Ischaemic injury 
Ischaemia is defined as developing "whenever the flow of 
arterial blood through the diseased vessels is reduced to a 
volume below that required by the myocardium for adequate 
function", and extended to "whenever the arterial blood flow 
is insufficient to provide enough oxygen to prevent 
intracellular respiration from shifting from the aerobic to 
the anaerobic form" (Jennings, 1970). This reduction in, or 
inadequacy of, blood flow leads to metabolic and contractile 
dysfunction because of a lack of oxygen and substrate supply, 
and of washout of metabolites. Ischaemia is an essentially 
reversible phenomenon depending on its severity and duration. 
If ischaemia is irreversible, this is infarction. Cardioplegic 
arrest represents the extreme, of global ischaemia, in which 
no flow exists. 
Ischaemic injury is observed as changes in the cellular 
ultrastructure including membrane disruption, mitochondrial 
swelling, oedema and shortening of the sarcomeres, with an 
overall reduction in contractile function (Jennings and 
Ganote, 1976; Schaper et al., 1979; Tranum-Jensen et al., 
1981). Contracture, or the so-called "stone heart" phenomenon, 
is a manifestation of severe ischaemic injury. 
These changes in the myocardium are thought to be brought 
about by a depletion in energy stores (Neely et al., 1973; 
Jennings and Ganote, 1976; Jennings et al., 1983), 
accumulation of waste products (Neely et al., 1973; Neely and 
Grotyohann, 1984) with subsequent inhibition of glycolysis 
(Ravetto, et al., 1975; Opie, 1988; Jennings et al., 1989; 
Owen et al., 1990), membrane disruption (Schaper et al., 1979; 
Jennings et al., 1983; Corr et al., 1984; van der Vusse et 
al., 1989), intracellular acidosis ( Cobbe and Poole-Wilson, 
1980a, 1980b), intracellular ca2+ accumulation (Clusin et al., 
1983; Nayler et al., 1988; Opie, 1989a; Tani and Neely, 1989, 
1990), free radical activity (Hess and Manson, 1984; Kako, 
1987; Vandeplassche et al., 1990), and activation of catalytic 
enzymes (Corr et al., 1984; van der Vusse et al., 1989). 
1) Energy production 
Energy continues to be consumed at the normal rate with the 
onset of ischaemia. However, a reduction in the supply of 
substrates and inhibition of high energy phosphate formation 
pathways reduces the rate of replenishment of energy stores. 
creatine phosphate ( CP) in the initial stages of ischaemia 
acts as a source of energy for the formation of adenosine 
triphosphate (ATP), but the levels are rapidly depleted. 
Oxidative phosphorylation is dependent on the amount of oxygen 
available to the cells. With a reduction in blood flow, oxygen 
supply is diminished which inhibits oxidative phosphorylation, 
and stimulates glycolysis by the Pasteur effect. ATP 
production via anaerobic glycolysis is small (4 ATP's per 
molecule of glucose) when compared to oxidative 
phosphorylation ( 36 ATP' s per molecule of glucose). However, 
in restricted oxidative phosphorylation, glycolysis becomes 
the major source of energy (Opie, 19 9 o) • Al though exogenous 
substrates are no longer available with ischaemia, glycogen 
can be utilised by this pathway.However, increased glycolysis 
leads to the formation of lactate and, indirectly, an increase 
in intracellular proton concentration (Opie, 1989c). These 
products accumulate with no washout and inhibit the enzymes of 
the glycolytic pathway (Rovetto et al., 1975). ATP production 
in the myocardium is therefore reduced with time of ischaemia. 
Changes in pH affect many of the processes in the cell ( see 
below) while lactate accumulation in the cell inhibits 
glyceraldehyde-3-phosphate dehydrogenase activity (Ravetto et 
al., 1975), causes mitochondrial damage, increases the osmolar 
load of the cells, and has certain electrophysiological 
effects, including a shortening of the action potential 
duration (Marrannes et al., 1975; Saman and Opie, 1984). 
ATP has a ubiquitous role in the cell, and a reduced level in 
the ischaemic myocardium is linked to many of the deleterious 
consequences of inhibition of flow. ATP is required for many 
cellular enzymatic reactions, including the ATP dependent 
Na+ /K+ pump, which maintains the electrophysiological status 
of the cells. This pump which removes 3 Na+ from the cell in 
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exchange for 2 K+, is responsible for the consumption of a 
large amount of the available energy in the cell and is 
therefore highly dependent on ATP levels (Kleber, 1984). 
Glycolytic ATP is thought to be especially important to the 
ischaemic myocardium. Jennings et al. (1989) found that a 
basal level of glycolysis in ischaemia is important, where its 
inhibition leads to rapid depletion in the reserves of high 
energy phosphates with consequent irreversible injury to the 
myocytes. 
There is evidence for a functional compartmentalisation of 
ATP. Bricknell and Opie (1978) suggested that the ATP produced 
by glycolytic flux during ischaemia plays a role in preserving 
the integrity of the membranes by maintaining sarcolemmal pump 
activity, while ATP from oxidative phosphorylation is used for 
contractile function (Weiss and Hiltbrand, 1985; Weiss and 
Lamp, 1987). Glycolytic ATP is associated with inhibition of 
the ATP sensitive K+ channel, and is thereby thought to reduce 
efflux of K+ via this mechanism during ischaemia (Weiss and 
Lamp, 1987; Kantor et al., 1990). Glycolytic ATP is also 
thought to be involved in the control of intracellular ca2+ 
levels with maintenance of the integrity of the cell membranes 
(Poole-Wilson et al., 1984), prevention of ischaemic 
contracture (Bricknell et al., 1981; Owen et al., 1990), 
inhibition of enzyme release (Hearse et al., 1976), and 
inhibition of free radical activity (Opie, 1989c). Glycolytic 
ATP may be available to maintain the phosphatidic acid cycle 
thereby preventing the accumulation of lysophospholipids which 
lead to membrane breakdown (Corr et al., 1984). 
2) Energy levels 
ATP levels have been used as indicators of the expected 
recovery of ischaemic hearts (Hearse et al., 1974; Nayler et 
al., 1979; Lazar et al., 1980). A critical limit on the level 
of ATP in the myocardium which determines the irreversibility 
of injury is thought to exist. However, the value of this 
limit is much debated (Opie, 1984). 
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Various reports as to the rate of decline of ATP levels in the 
ischaemic myocardium have been published. A reduction in ATP 
of 25% after 2 min, and of 70% by 20 min of low flow ischaemia 
in the isolated rat heart was found (Neely et al., 1973). CP 
levels decline more rapidly by about 70% after 2 min, acting 
as a source of energy for ATP formation (Neely et al., 1973). 
A comprehensive study by Edoute et al. (1983) shows a fairly 
linear drop in ATP levels with duration of ischaemia, which 
was in turn associated with a drop in function on reperfusion. 
CP levels were almost all severely depressed at the end of 
ischaemia. 
However, more recent studies have found a lack of correlation 
of high energy phosphate levels at the end of ischaemia with 
the functional recoveries of the hearts on reperfusion (Neely 
and Grotyohann, 1984; Taegtmeyer et al., 1985; Saks et al., 
1989; Steenburgen et al., 1990). 
Taegtmeyer et al .. ( 1985) found a reduction in ATP levels of 
38% after 5 min, 56% after 10 min, and 79% after 20 min global 
ischaemia in isolated rat hearts. There was no functional 
recovery after 20 min ischaemia. CP levels dropped by 83% 
after 5 min, and by 88% after 10 min ischaemia. ATP levels 
were widely spread in correlation to recovery after 20 min 
ischaemia, whereas CP levels were grouped together. For longer 
periods of ischaemia, with a greater decrease in high energy 
phosphate levels, a better correlation was found but only with 
severe impairment of myocardial function. 
Neely and Grotyohann (1984) found that ATP levels declined to 
about 85% of control values after 30 min ischaemia, but no 
further decreases with longer periods of ischaemia were 
observed (60 min). Little correlation with recovery of 
contractile function was found. By 90 min ischaemia, Jennings 
et al. (1989) found a drop in ATP levels to 3-4% of controls, 
with no recovery of contractile function. 
In the dog heart, Reimer et al. ( 1981) found a depletion of 
ATP of 65% of control levels after 15 min severe myocardial 
ischaemia, although no necrosis was observed. 
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The free energy of hydrolysis derived from ATP in hypoxic 
hearts is reduced (Kammermeier et al., 1982), while a 
reduction in the efficiency of the conversion of the chemical 
energy from ATP to mechanical tension at low pH's (as found in 
ischaemic myocardium) is found (Takayasu et al., 1990). It is 
therefore not only a reduction in the amount of ATP during 
ischaemia which may be responsible for a depression in 
contractile function. 
While a direct correlation of ATP with contractility after an 
ischaemic period does not necessarily hold, many of the 
changes occurring in the ischaemic myocardium are dependent on 
the availability of energy. The multi factorial effects of a 
decrease in ATP levels with ischaemia may combine to 
contribute to the reduction in functional recovery. 
3} pH 
The onset of ischaemia is associated with a rapid drop in pH 
(Cobbe and Poole-Wllson, 1980a). With global ischaemia, tissue 
pH falls from an initial value of 7.2 by 0.15 units (pH 7.05) 
by 5 min, 0.66 units (pH 6.54) by 15 min, and by as much as 
1.4 units (pH 5.8) by 60 min (Cobbe and Poole-Wilson, 1980a). 
The initial decline in pH is thought to be due to an immediate 
increase in pco 2 from usage of residual oxygen (Case et al., 
1979), and subsequent acidosis is attributed mainly to the 
hydrolysis of ATP, with increased glycolysis and inhibition of 
oxidative phosphorylation. An increased glycolytic rate is 
associated with a decreasing pH because the rate of ATP 
the uptake of production and 
phosphorylation is reduced compared 




rate of ATP 
Acidosis in the normally functioning heart is associated with 
decreased contractility (Eisner et al. , 1982). A fall in pHi 
of O. 2 uni ts leads to a 50% decline in developed tension 
(Poole-Wilson, 1989). This has been attributed to the 
increased competition between H+ and Ca 2+ ions for binding 
sites (Berman et al., 1977; Langer, 1985; Pressler, 1987). 
Acidosis decreases the sensitivity of the troponin-tropomyosin 
complexes of the myofilaments to ca 2+ (Chapman, 1983; Barry et 
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al., 1987) and decreases the maximum tension developed at 
saturating levels of ca2+ (Eisner et al., 1982; Langer, 1985). 
A reduction in the uptake and release of ca 2+ by the 
sarcoplasmic reticulum occurs at a low pH ( Berman et al. , 
1977; Allen and Orchard, 1983), which is thought to reduce 
Ca 2+ cycling essential for normal contractile function. Ca 2+ 
binding to the membrane phospholipids is reduced (Langer, 
1985) with release of Ca 2+ into the cytosol. Cell to cell 
coupling is decreased with a reduction in junctional 
conductance (De Mello, 1982; Pressler, 1987). 
However, in the hypoxic heart, acidosis (pH 6.8) has a 
protective effect resulting in improved recovery on 
reoxygenation (Bing et al., 1973). This is attributed to 
greater conservation of energy stores by the depressive 
effects of an acidotic pH on contractility and substrate 
transport, especially during the early stages of hypoxia. 
Nayler et al. (~979) also found that a mild respiratory 
acidosis is beneficial to an hypoxic heart, with preservation 
of mitochondrial activity and stores of ATP as well as a 
reduction in the rate of tension development. Prevention of 
ca 2+ accumulation in the cell and mitochondria is also found 
during arrest with a low pH (Yates and Dhalla, 1975; Nayler et 
al., 1979; Busselen, 1985; Nayler et al., 1988; Opie, 1989a), 
with preservation of ATP stores and restoration of oxidative 
phosphorylation on reperfusion. 
Ca 2+ transport occurs after a 
Philipson et al., 1982) as pH 
A reduction in sarcolemmal 
fall in pH (Bielecki, 1969; 
affects the fluidity of the 
membranes and is thereby a deterrent to ca2+ entry (Pressler, 
1987). The Na+;ca 2+ exchanger is also directly inhibited by 
acidosis in sarcolemmal vesicles isolated from cardiac cells 
(Philipson et al., 1982). The reduction in the ability of the 
sarcoplasmic reticulum (SR) to sequester and release ca2+ with 
a reduced pH (Berman et al.,1977) may also help in the 
preservation of energy stores. 
Thus the reduction in intracellular pH in the ischaemic 
myocardium may be a protective reaction initially. However, 
with prolonged ischaemia, intracellular pH may be reduced to 
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levels leading to cell necrosis with irreversible injury. This 
may be due to inhibition of the catalytic activity of many key 
enzymes and activation of proteases and lipases (Corr et al., 
1984) leading to breakdown of the membranes. An intracellular 
proton accumulation may also lead to intracellular Na+ 
overload via the Na+ /H+ exchanger (Lazdunski et al., 1985; 
Kaila and Vaughan-Jones, 1987), an electroneutral reversible 
anti port with a 1: 1 stoichiometry (Kaila and Vaughan-Jones, 
1987). This may lead to subsequent ca2+ influx via the 
Na+ /Ca 2+ exchanger ( Tani and Neely, 1990) • However, during 
ischaemia, with a reduction in intracellular pH and subsequent 
extracellular equilibration, the Na+ /H+ exchange is largely 
inhibited. 
The levels of enzyme leakage are used as a diagnostic 
indicator of cellular membrane damage (Hearse et al., 1973; 
Hearse et al., 1975). Membrane integrity is very important in 
determining both ~he degree and extent of injury, as well as 
its reversibility. If a large proportion of the total membrane 
surface area in the myocardium is damaged, the cells will 
probably be irreversibly damaged, as large gaps in the 
membrane cannot easily be mended. 
4) Calcium influx 
ca 2+ plays a central role in the regulation of cellular 
functions (Lucchesi, 1989), including modulation of the rate 
of ATP utilisation, triggering of contractile activity, and 
maintenance of the integrity of the plasma membranes (Frank et 
al., 1977) and the intercalated discs (Rim et al., 1990). 
However, during ischaemia, there is an excess influx of ca 2+ 
(Kihara et al., 1989), and reduced ability of the cells to 
handle this increase. 
ca 2+ 1s thought to enter ischaemic cells by a number of 
mechanisms. There is a drop in resting membrane potential with 
ischaemia, due to K+ efflux, which may open the L - type ca2+ 
channels. However, this means of ca2+ entry 1s strongly 
debated (Fozzard and Makielski, 1985; Coetzee, 1988). Another 
means of ca2+ entry which has been proposed is via the 
Na+;ca 2+ exchange following intracellular Na+ accumulation, 
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either from activation of the Na+;H+ exchange (Bers and Ellis, 
1982; Lazdunski et al. , 1985) or by inhibition of the ATP-
dependent Na+;K+ pump by a reduction in ATP levels (Ellis and 
MacLeod, 1985 Kaila and Vaughan-Jones, 1987). The Na+;ca 2+ 
antiport is thought to carry 3 Na+ ions for each ca 2+ ion via 
a protein ( Reuter and Seitz, 1968; Reeves and Sutko, 1979; 
Philipson, 1985; Eisner and Lederer, 1985; Kimura et al., 
1986). The energy driving this exchange is provided by the 
concentration gradients of both ions, and the transmembrane 
potential (Eisner and Lederer, 1985). The exchange is 
therefore reversible, which can lead to the intracellular 
accumulation of ca2+ when there is a high intracellular Na+ 
concentration and a depolarisation of the membrane (Chapman, 
1983; Lazdunski et al., 1985; Kaila and Vaughan-Jones, 1987; 
Tani and Neely, 1989; Vaughan-Jones et al., 1989). 
A predominant mechanism for ca2+ entry is thought to be 
diffusion through leaky membranes down its concentration 
gradient ( Chapman et al. , 1984; Nayler et al. , 1988) . The 
holes in the membrane formed during ischaemia are exacerbated 
by the increasing levels of free ca2+ in the cell, which 
reduces the stability of the cellular membranes. ca2+-
dependent phospholipases present in the membrane are activated 
by an increase of calcium ( Rim et al. , 1990) . Lipid 
peroxidation occurs with the appearance of holes in the lipid 
bilayer through which intracellular enzymes and myoglobin are 
lost. Conformational changes of the membrane also occur with 
inhibition of sarcolemmal ATPase activity ( Limbruno et al. , 
1989) . Ca 2+ sensitive proteases may be activated which also 
cause damage within the cell and to the cell membranes (Nayler 
et al., 1988; Rim et al., 1990). 
Intracellular accumulation of free ca2+ may also be due to 
reduced uptake by the SR and a lower buffering capacity of the 
cytosol. With a drop in ATP levels, Ca 2+ sequestration from 
the cytosol is reduced (Smith and Allen, 1988) as ca2+ pumps 
in the sarcoplasmic reticulum and sarcolemma are highly 
dependent on ATP 
intracellular acidosis, 
(Carafoli, 1985). With ischaemic 
the affinity of ca 2+ binding sites is 
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reduced and the ca 2+ buffering capacity of the cytosolic 
proteins is inhibited (Bers and Ellis, 1982; Kohomoto et al., 
1990). 
ca 2+ is accumulated in the mitochondria at the expense of ATP 
by the electron transport chain, using the proton gradient, or 
by ATP dependent processes (Pesaturo and Gwathmey, 1990). With 
extended ischaemia, calcium phosphate granules are deposited 
in the mitochondria (Jennings and Ganote, 1976). ca2+ overload 
results in an impairment of mitochondrial function. 
5) Potassium efflux 
Potassium efflux and extracellular accumulation are known to 
be primary consequences of ischaemia (Kleber, 1983; 1984; 
Fozzard and Makielski, 1985). Resting membrane potential 
decreases soon after restriction of flow, and the amplitude 
and duration of the transmembrane action potentials are 
reduced (Kleber et al., 1978; Morena et al., 1980; Kagiyama et 
al., 1982; Manning and Hearse, 1984). 
K+ loss from myocardial cells is attributed to a number of 
mechanisms including opening of the ATP dependent K+ channel 
(Kantor et al., 1990). There is also a large efflux of K+ down 
its concentration gradient. At rest, the membrane has a high 
permeability to K+, resulting in a constant flux of K+ out of 
the cell. The ATP dependent Na+ /K+ pump acts to restore the 
gradient. However, when ATP is depleted in ischaemia, this 
pump is no longer active. Loss of K+ and extracellular K+ 
accumulation during hypoxia and ischaemia depolarises the 
membrane (Manning and Hearse, 1984), with resting membrane 
potentials of -50 mV recorded by late ischaemia (Kleber, 
1983). 
b) Reperfusion injury 
Myocardial damage and poor heart function result both from 
ischaemia and the subsequent period of reperfusion (Opie, 
1989b). Ischaemia is thought to predispose the myocardium to 
injury which is exacerbated on reperfusion, where the severity 
of reperfusion injury is thought to be directly related to the 
extent of ischaemic injury. There is a paradoxical need for 
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reperfusion of the ischaemic tissue, even though this appears 
to cause widespread damage. 
Reperfusion damage may be apparent 1n myocardial swelling and 
a depression of ventricular function (Opie, 1989b; Laster et 
al., 1989). An inability of the post-ischaemic tissue to make 
efficient use of delivered o2 (Laster et al., 1989), increased 
oedema upon reperfusion, with stretching of the membranes and 
mechanical abrasion, intracellular accumulation of ca 2+, and 
increased oxygen free radical activity (Kao et al., 1986) are 
factors leading to permanent damage of the cells. 
Pathological consequences of ischaemia include reperfusion 
arrhythmias. The phenomenon of "stunning", a reversible 
depression of function after an ischaemic period, has also 
been described (Braunwald and Kloner, 1982). Stunning may be a 
protective phenomenon, possibly allowing the heart a period of 
rest after the ischaemic insult. However, in the clinical 
situation, an immediate and complete restoration of mechanical 
functioning of the heart may be required. 
1) Restoration of ATP levels 
Levels of ATP on reperfusion are gradually restored although 
control levels are not reached for some time. A significant 
correlation of ATP content of hearts at the end of ischaemia 
with percentage recovery of work performed has been observed 
( Edoute et al., 1983). This was after differing periods of 
ischaemia. Reperfusion for 30 min led to an increase in ATP 
levels, although these did not reach preischaemic values. 
While ATP levels at the end of the ischaemic period must be 
above a certain level to ensure reversibility of damage, 
restoration of the mechanisms of ATP production on 
reperfusion, especially oxidative metabolism, may be more 
important (Reimer et al., 1981; Taegtmeyer et al., 1985; 
Laster et al., 1989; Saks et al., 1989). 
During ischaemia, the precursors of ATP, 
inosine and hypoxanthine leak out 
reperfusion, these are washed out, 
restoration of ATP formation (Reimer 
including adenosine, 
of the cells. On 
which delays the 






ATP on reperfusion is therefore 
function is also thought to be 
disrupted during ischaemia and subsequently exacerbated on 
reperfusion ( Edoute et al., 1983). Reperfusion is associated 
with a depression in mitochondrial oxidative function, and 
the ref ore reduced ATP production. Controversy exists as to 
whether mitochondrial damage occurs during ischaemia, or is 
exacerbated on reperfusion. Disruption to the compromised 
mitochondria, observed during ischaemia as swelling and 
formation of dense granules (Jennings and Ganote, 1976; Edoute 
et al., 1983) may be exacerbated by the ca2+ influx observed 
on reperfusion (see below). The damage to the mitochondria may 
contribute to the delay in the restoration of ATP on 
reperfusion. 
Laster et al. (1989) observed no absolute change in myocardial 
oxygen consumption in the post-ischaemic "stunned" myocardium 
but a depressed contractile function was observed. An increase 
in oxygen consumption per unit work was therefore found on 
reperfusion, indicating a decrease in the efficiency of energy 
consumption and usage, possibly associated with mitochondrial 
damage. 
Alternatively, Saks et al. (1989) found that mitochondrial 
oxidative phosphorylation (in skinned myofibrils) was found to 
be tolerant to an ischaemic period which reduced contractile 
function. It was suggested that the decreased function is a 
result of disturbance of the contractile function or 
electromechanical coupling. 
CP levels are immediately restored on reperfusion (Taegtmeyer 
et al., 1985) although creatine kinase and its coupling to 
oxidative phosphorylation are impaired with ischaemia (Saks et 
al., 1989). 
2) Calcium overload 
One of the major putative causes of reperfusion injury is an 
excessive influx of Ca 2+ ( Clusin et al., 1983; Nishioka et 
al., 1984; Poole-Wilson et al., 1984; Nayler et al., 1988). 
During ischaemia, membrane damage occurs (Corr et al., 1984), 
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together with an intracellular overload, possibly 
following acidosis ( Lazdunski et al., 1985). On reperfusion, 
these changes initiate an influx of ca2+ in addition to that 
occurring during ischaemia, in excess of that which can be 
handled by the cytosolic ca 2+ buffering and uptake capacities 
(Kohomoto et al., 1990). ca 2+ uptake by the SR is still 
depressed on reperfusion (Krause et al., 1989) while there is 
an increased sarcolemmal permeability to ca 2 + (Nishioka et 
al., 1984). The excess ca 2+ is thought to be responsible for 
much of the reduced function on reperfusion, which may be due 
to a breakdown in excitation-contraction coupling (Krause and 
Hess, 1984; Krause et al., 1989; Limbruno et al., 1989). 
With the massive influx of calcium on reperfusion, there is a 
need for increased uptake of ca2+ by the SR by energy 
consuming processes, in the face of a depletion of energy 
stores. Additional Ca 2+ overload of the mitochondria occurs, 
with the deposi ti~n of granules, as these organelles are a 
maJor buffer for this ion (Carafoli, 1985; McGuigan and 
Blatter, 1987). This depresses oxidative phosphorylation, 
while bands of contracture appear in the myocardium, 
decreasing energy stores further. 
A maJor mechanism for the entry of ca 2+, especially on 
reperfusion, is thought to be by increased activity of the 
Na+;ca 2+ exchanger (Burt and Langer, 1982; Chapman et al., 
1984; Chapman et al., 1986). On reperfusion with a relatively 
alkalotic perfusate (blood pH 7. 4), the Na+ /H+ exchanger may 
be activated, which leads to the protons being extruded, and 
pH returned to normal, but with a concomitant increase in 
intracellular Na+. 
Intracellular Na+ accumulation is also associated with 
cellular swelling and oedema due to the retention of salt. Cl-
enters the cell because of the change in the electrochemical 
gradient. The Donnan equilibrium is upset, with loss of 
regulation of cell volume, and an increased vascular 
resistance. Disruption of the sarcolemmal membranes on 
reperfusion, decreased perfusion of the vascular bed and 
reduced removal of accumulated waste products result. 
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3) The calcium paradox 
In the special case of an absence of extracellular ca2+, as 
occurs with the use of an calcium-free cardioplegic solution, 
re-exposure to a ca 2+-containing perfusate results in the 
appearance of the calcium paradox (Zimmerman and Hulsmann, 
1966; Bielecki, 1969; Yates and Dhalla, 1975; Chapman et al., 
1984). This phenomenon is paradoxical as the heart requires 
Ca 2+ for its normal function, but when reintroduced after a 
period of acalcaemic perfusion, results in a large depression 
in function and severe ultrastructural damage. Observed 
effects are a change in colour of the myocardium, a decrease 
in electromechanical activity with severe contracture, and an 
increase in the loss of LDH and other enzymes with changes in 
the cellular ultrastructure (Nayler et al., 1988; Hess and 
Manson, 1984; Yates and Dhalla, 1975). There are many 
similarities between this phenomenon and reperfusion after an 
ischaemic period. 
When ca 2+ is removed from the extracellular space, the 
external lamina and glycocalyx of the sarcolemma separate, 
while swelling and margination of the mitochondria occur 
because of an increase in membrane fluidity ( Frank et al., 
1977; Langer, 1978). On reperfusion with a calcium containing 
perfusate, there is an excessive influx of ca2+ because of 
damage to the sarcolemmal membranes, as well as other factors 
including intracellular Na+ overload (Hess and Manson, 1984). 
The formation of oxygen free radicals associated with 
reoxygenation may also disrupt the functioning of the membrane 
(McCord, 1985; Kako, 1987; Opie, 1989b). Free radical 
generation depresses the rate of ca2+ uptake of the SR of the 
myocardium, and the Na+;ca2+ exchange and the Na+;K+ ATP 
dependent pump may be also be affected (Kako, 1987). 
While acidosis (Bielecki, 1969) and Mg 2+ (Bhojani and Chapman, 
1990) have been found to protect the heart against the ca2+ 
paradox, alkalosis (Bers and Ellis, 1982), extracellular Na+ 
depletion and high extracellular K+ all increase ca2+ influx 
( Torchiana et al., 1987). Oxygen free radical formation is 
also thought to be linked to the calcium paradox (Hearse et 
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al., 1978; Hess and Manson, 1984; Opie, 1989b), where an 
accumulation of intracellular ca2+ may trigger the formation 
of these reactive molecules. 
4) Free radical formation and the oxygen paradox 
The oxygen paradox is observed on the reintroduction of oxygen 
after a period of hypoxia or ischaemia, the conditions of 
which predispose the tissue to the formation of free radicals. 
This phenomenon is thought to be mediated by the metabolism of 
molecular o2 . 
Several mechanisms for the formation of oxygen free radicals 
have been proposed (Hess and Manson, 1984; McCord, 1987). 
These intermediates are normally produced by the cells from 
about 5% of available oxygen, but these are broken down by 
naturally occurring free radical scavengers (Hess and Manson, 
1984). During ischaemia, these enzymes may be inhibited. 
Another possible mechanism has been proposed by McCord (1985; 
1987). During the ·hypoxic or ischaemic phase, changes such as 
the accumulation of the breakdown products of ATP, including 
xanthine and hypoxanthine, and intracellular ca2+ overload 
occur. Intracellular accumulation of ca 2+ is thought to 
activate a protease, possibly calpain, which converts the 




to urate with the 
this enzyme will convert 
formation of free radicals. 
This process has been identified as a significant contributor 
to oxygen free radical formation in the heart, primarily in 
the capillary endothelial cells (Chambers et al., 1989) 
Oxygen free radicals are highly reactive molecules which react 
with many compounds in the cell (McCord, 1985, 1987; Kako, 
1987). This leads to denaturation of proteins (Prinsze et al., 
1990) and peroxidation of phospholipids with subsequent 
membrane degeneration (Gutteridge and Halliwell, 1990). Loss 
of normal mitochondrial and SR function, altered membrane 
permeability, disorganisation of the myofibrils and disruption 
of the cellular transport processes occur depending on the 
duration of hypoxia (Gaudel and Duvelleroy, 1984; Miki et al., 
1988; Menasche and Piwnica, 1989; Vandeplassche et al., 1990). 
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Free radicals may affect proteins by conformational changes in 
amino acid residues and 1n susceptibility to enzymes and 
denaturation (Kako, 1987). 
The reversible decrease in contractile function evident on 
reperfusion, described as "stunning", may also be mediated by 
oxygen free radicals. Bolli et al. (1989) provided evidence of 
free radical-induced cellular damage responsible for stunning 
developing in the initial seconds after reperfusion. Free 
radical activity has also been associated with reperfusion 
arrhythmogenesis (Woodward and Zakaria, 1985 although this has 
been disputed ( Coetzee et al. , 1990) . Membrane degeneration 
associated with free radical activity was found to be delayed, 
after the manifestation of early reperfusion arrhythmias 
( Coetzee et al. , 1990) . The interrelationship between free 
radical activity and ca 2+ has been strongly emphasised (Hearse 
et al., 1978; Hess and Manson, 1984; Opie, 1989b). 
5) Reperfusion arrhythmias 
These are a pathological 
extreme circumstance of 
consequence of ischaemia, the most 
which is ventricular fibrillation 
(VF) , which leads to a critical decrease in cardiac output 
(Manning and Hearse, 1984), with increases in wall tension and 
energy consumption in the face of a depleted availability of 
oxygen. VF is a common clinical finding on reperfusion after 
cardio-pulmonary bypass, and its prevention is of critical 
importance (for review see Manning and Hearse, 1984). 
Indices such as shorter refractory periods and uncoordinated 
depolarisation cause disruption of the normal heart rhythm 
with the resultant effect that the tissue is no longer in a 
functional syncytial state and cannot act as a cohesive unit. 
Alterations during ischaemia and on reperfusion including K+ 
efflux and extracellular accumulation, free radical activity, 
ca 2+ overload, inhibition of glycolytic activity (Bernier and 
Hearse, 1988; Kantor et al., 1990) and increases in cyclic 
adenosine monophosphate (cAMP) levels (Opie, 1982) are thought 
to contribute to arrhythmic activity on reperfusion. 
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iv) Objectives of a cardioplegic solution 
The objectives of a cardioplegic solution are, according to 
Buckberg and Rosenkrantz ( 1987), "to stop the heart safely, 
create an environment for continued energy production, and 
counteract deleterious effects of ischaemia". Maximal recovery 
may be achieved not only by inhibition of extreme myocardial 
damage but also by avoiding all ischaemic injury. Cardioplegic 
solutions are therefore formulated on the basis of the changes 
occurring during ischaemia. Additional criteria for an 
improved solution include ease of administration, lack of 
complications during surgery, and ease of manipulation of the 
basic composition. 
The basic requirements of a cardioplegic solution have been 
stipulated (from Buckberg, 1979; Bretschneider, 1980; Hearse 
et al., 1981; Buckberg and Rosenkrantz, 1987): 
a) Immediate arrest 
Arrest of the heart must be immediate, complete and 
reversible, without detrimental side effects. The heart must 
remain in an arrested state without intermittent recurrence of 
activity for the duration of the arrest period. The membrane 
must be stabilised and irreversible damage prevented. 
b) Energy conservation 
Energy must be conserved in order to counteract the adverse 
effects of ischaemia, as many functions are determined by the 
level of stored energy in the cell. 
A fundamental approach when formulating an efficient 
cardioplegic solution is based on improved energy status of 
the heart. This may be by either increasing energy production 
(intracellular and extracellular sources); or by reduction of 
energy demand. The balance of these two factors is thought to 
be critical in determining the recovery of the hearts 
(Bretschneider, 1980). 
Energy demand is brought about by 
- basal metabolic rate 
- continued electromechanical activity 
.... 
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- wall tension 
Energy demand in an arrested heart may be reduced by a number 
of interacting factors. 
- Hypothermia is conventionally used (Buckberg, 1979), which 
leads to a reduction in metabolic rate while also suppressing 
contractile and transmembrane ATPase activity (Fukumoto et 
al., 1990). All reactions and processes in the myocardial 
tissue are slowed down at low temperatures and the consumption 
of ATP is decreased. 
Electromechanical 
manipulation of the 
solution. Usage of 
consequently reduced. 
activity may also be inhibited by 
ionic composition of the cardioplegic 
ATP by membrane pump mechanisms is 
Wall tension can be reduced by inhibiting intracellular 
accumulation of ions such as ca 2+, as this leads to 
contracture with increasing ATP consumption. 
Energy production can be increased by 
- the addition of substrates for anaerobic energy production. 
However, there are harmful end products associated with an 
increased rate of glycolysis, including lactate and protons. 
The accumulating end metabolites act to inhibit glycolysis, 
and have other harmful effects on the myocytes. The simple 
addition of substrate is therefore not always beneficial but 
may sometimes be deleterious. The relative contribution of 
these converse effects must be determined in the overall 
recovery of the hearts. Further alterations to the solution 
may be required to enhance the effect of the initial 
modification. 
- increasing the supply of oxygen and consequently oxidative 
phosphorylation. This is a much more efficient energy pathway 
than glycolysis, without the accumulation of metabolites. 
c) Adequate buffering 
Buffering is required to prevent large changes in pH which are 
associated with ischaemia. 
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d) Osmolarity 
Osmolarity must be maintained to prevent cell and tissue 
damage by oedema, especially on reperfusion. 
e) Inhibition of reperfusion injury 
On reperfusion of the heart, restoration of the ionic 
gradients must be immediate, and phenomena such as oedema and 
distension of the ventricles, ventricular fibrillation, 
ventricular collapse, and development of necrotic tissue must 
be avoided. Free radical activity and excess ca 2+ influx must 
be inhibited. 
Reperfusion injury has been the focus of increasing interest 
in recent literature (Braunwald and Kloner, 1982, 1985; 
Jennings et al., 1985; Opie, 1989b). This may be mitigated in 
two ways; by developing a specific reperfusion solution; or by 
minimising ischaemic damage. The latter is the aspect of major 
concern in our investigation. 
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v) The St Thomas' Hospital cardioplegic solution No 2 
a) Basis of formulation 
The St Thomas' Hospital Cardioplegic solution No. 2 (ST) has a 
basic ionic composition (Table 1), with a proven record both 
in the laboratory and clinically. However, we felt that 
further changes could be made to this solution to optimise 
recovery of the hearts. 
The ST cardioplegic solution has a high potassium 
concentration as the cardioplegic agent, and is used under 
hypothermic conditions. This leads to rapid arrest of the 
heart and substantially reduces metabolic rate. The solution 
is normally infused at a temperature of 4-10°c, which 
decreases the metabolic rate without disrupting the cells due 
to the formation of ice crystals. The higher temperatures 
within this range have been shown to be more beneficial in 
preservation of hearts (Tyers et al., 1977; see Hearse et al., 
1981 for discussion), after monitoring of various biochemical 
parameters including myocardial ATP content, and recovery 
after arrest. 10°c and 15°c resulted in the best recoveries, 
while 5°c, 20°c and 37°c reduced function (Tyers et al., 
1977) . This has been corroborated in several other studies 
using different models (see Hearse et al., 1981). 
The osmolality of the ST solution is maintained at about 
300 mOsm/kg H2o which is slightly above extracellular values 
(Table 1). The osmolality is maintained to prevent the 
development of intracellular oedema which is especially 
important in preventing reperfusion damage. 
b) K+ concentration 
The ST solution has an optimal K+ concentration of 16 mmol/1. 
A high K+ concentration has been found to act synergistically 
with a decreased temperature in suppressing electrical 
activity in the cells (Hearse et al., 1975; Ferguson et al., 
1986) The development of an action potential is prevented by 
an increased K+ concentration as membrane potential is 
reduced. With 16 mmol/1 K+, the membrane potential is about -
55 mV. At this potential, the Na+ and ca2+ channels are 
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inactivated. With a higher K+ concentration, ca 2+ channels 
will be activated, which is undesirable. 
A large K+ concentration gradient and a relatively high 
permeability of the membrane to the ion during ischaemia cause 
efflux of K+. Intracellular K+ concentration must be 
maintained, usually with the expenditure of energy. With a 
high extracellular K+ concentration, this energy expenditure 
1s reduced. 
c) Na+ concentration 
A concentration of 120 mmol/1 Na+ is used in the ST solution. 
A more reduced Na+ concentration would prevent the development 
of an action potential, but too low an extracellular 
concentration may cause Ca 2+ influx across the sarcolemma by 
activation of the Na+;ca 2+ exchange mechanism, which is 
dependent on the gradients of Na+ and ca 2+ across the cell 
membrane (Chapman et al., 1984; Eisner and Lederer, 1985). Na+ 
must therefore be· maintained at near normal levels. A dose 
response curve indicates that a concentration 
120 mmol/1 1s optimal for cardioplegic solutions 
1980) . 
d) ca2+ and Mg2+ concentration 
of 100-
(Jynge, 
ca 2+ must be present in a cardioplegic solution at a minimum 
concentration of 50 µmol/1, to prevent the calcium paradox 
phenomenon upon reperfusion of the heart ( Hess and Manson, 
1984). The ST solution uses a concentration of ca2+ of 1. 2 
mmol/1 which is similar to that usually found in the 
extracellular medium (Yamamoto et al., 1984; Ledingham et al., 
1987). This relatively high concentration can be used because 
of the presence of a high Mg 2+ concentration. 
The triggering action of ca 2+ in excitation-contraction 
coupling of the myocardium with subsequent consumption of 
energy is inhibited by Mg 2+ which competes with ca 2+ binding 
sites (Hearse et al., 1978a). ca2+ entry is blocked and the 
Ca 2+ ATPase of the SR is activated in the presence of Mg 2+, 
thereby increasing Ca 2+ uptake. A concentration of 16 mmol/1 
is recommended for the ST solution (Hearse et al., 1978; 
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Torchiana et al., 1987; Geffin et al., 1989; Reynolds et al., 
1989). 
e) Hco3- concentration 
The bicarbonate system (NaHco 3/H 2co 3 ) 
blood although its capacity is fairly 
6.35 (at 25°c). It plays an important 
in the face of changes in the co2 
is a maJor buffer in 
weak even at its pK of 
role in maintaining pH 
concentration. Carbon 
dioxide, freely permeable across the plasmalemma, determines 
the intra- and extracellular pH to a large extent. 10 mmol/1 
HC0 3- is included in the ST solution, to buffer the effects of 
ischaemia on pH. 
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vi) Clinical models - in situ aortic cross clamping and ex 
vivo donor heart storage 
There are two main strategies for the usage of a cardioplegic 
solution. In situ cardio-pulmonary bypass with subsequent 
aortic cross-clamping allows surgery to be performed in a 
bloodless field. Donor heart storage allows for harvesting of 
hearts for transplantation. In both cases, an extension of the 
time of arrest while ensuring maximum recovery is required. 
There are slight differences in the principles involved in the 
above procedures ( Table 2) , where hearts in situ in aortic 
cross-clamping are in the presence of non-coronary collateral 
flow ( blood flow from the surrounding tissue). This provides 
an external supply of substrates, but also washes out the 
cardioplegic solution and reduces hypothermia (Buckberg, 
1979). This may or may not be advantageous. To combat these 
effects, the hearts can be intermittently flushed with 
cardioplegic solution during the arrest period. This may 
confer additional advantages to the arrested heart, such as 
provision of substrate, and removal of metabolites. 
In donor heart storage, the environment is more consistently 
controlled. Donor heart storage can be of two kinds: 
continuous perfusion of cardioplegic solution at low 
pressures, or intermittent flushing; or simple hypothermic 
storage in a protective medium. There are advantages to both 
these methods. Low pressure perfusion and intermittent 
flushing of the heart, while possibly resulting in better 
recoveries, are impractical if the heart is to be transported 
over any distance. Simple immersion of the heart after a 
single flush of solution is more feasible although the 
recoveries are not always as good. 
The choice of cardioplegic solution used in either of the 
above situations is made by consideration of factors including 
ease of administration, and possible complications which may 
arise from storage of the solution over long periods. Changes 
in the myocardium over time may differ depending on the 
protocol used, which may in turn determine the values of 
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variables such as pH and the degree of oxygenation of the 
cardioplegic solution. 
Cardioplegic solutions for use during cardiac bypass have been 
well studied. Recently, there has been emphasis placed on 
solutions specifically for long term storage of donor hearts. 
These solutions have generally been developed for pulmonary or 
renal preservation (Baumgartner, 1990) and then applied to 
myocardial preservation. These solutions include Belzers's (or 
University of Wisconsin) solution (Belzer and Southard, 1988), 
the Euro-Collin's solution (Reitz et al., 1974) and the Sacks 
solution (Thomas et al., 1975). These solutions generally have 
a high K+ (comparable to intracellular levels) and a low Na+, 
with no ca 2+. As yet few clinical studies have been made with 
these solutions. The ST solution has been proved with cardiac 
bypass, and its use may be extended for long term preservation 
by manipulation of the formulation. 
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Table 2: Comparison of in situ cardio-pulmonary bypass and ex 
vivo donor heart storage with simple immersion. 
Cardio-pulmonary bypass Donor heart storage 
-Lowest attainable myocardial temperature 
12-16°c 4-10°c 
-Non coronary collateral flow 
washout of cardioplegia 
supply of substrate 
reduction in hypothermia 
-Relatively short term 
arrest period 
-Diseased hearts 
-Handling of the heart 
-Mechanical abrasion with 
flushing 
-Removal of waste products 
-Substrates can be supplied 
intermittently 
-Totally isolated in storage 
medium 
-Extended period of arrest 
-Healthy hearts 
-Relatively little handling 
during storage 
-Ionic imbalance over time 
with no flushing 
-Possible build up of waste 
products with no flushing 




i) The isolated heart apparatus 
The isolated working rat heart model was used to test the 
different cardioplegic solutions. The apparatus used was first 
described by Langendorff (1895), and modified by Neely et al. 
(1967). A diagram of the apparatus used is shown in Figure 1. 
It consists of essentially three different parts; the 
Langendorff unit for the initial perfusion and stabilisation 
of the heart in a retrograde mode; the working heart side for 
the measurement of indices of cardiac function with a preload 
of 20 cm H2o and an after load of 100 cm H2o; and a storage 
unit allowing cardioplegic solution to be introduced to the 
heart via the aortic cannula. The temperature on the perfusion 
side was maintained at 37°c, while the cardioplegic side was 
kept at 10°c. This temperature has been cited as being optimal 
for cardioplegic solutions (Tyers et al., 1977; Hearse et al., 
1981). Coronary effluent in the working mode was collected and 
recirculated as this has been shown to improve recoveries, by 
preventing a loss of protein from the perfusate. The 
recirculated solution was filtered before being reintroduced 
to the reservoir. 
The aortic and left ventricular cannulas can be closed off 
using the three way taps, and removed from the circuit. This 
'head' can then be placed in a reservoir for maintenance 
during arrest. Another set of cannulas can then be connected, 
to be removed in a similar fashion. This enables up to three 
experiments to be run concurrently. Maintenance of the hearts 
during arrest was set up so as to allow intermittent flushing 
with cold cardioplegic solution of three hearts simultaneously 
from a central vessel; or for simple storage at hypothermia. 
Pressure measurements were taken via the aortic cannula and a 
Statham Gould P32ID transducer, and recorded on a Grass Model 
79D polygraph (Grass Instrument Co., Quincy, Mass. USA). 
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t Directicn or flow 
Fig. 1. The isolated working rat heart perfusion apparatus 
with cardioplegic reservoir. The perfusion solution is Krebs-
Henselei t buff er, gassed with 95%0 2 5%co 2 and maintained at 
37°c. The entire perfusion rig is water-jacketed to ensure 
that the temperature is maintained. Perfusion pressure on the 
Langendorff side is 
the working heart 
100cm H2o, and preload and after load on 
side are 20cm H2o and 100cm H2o 
respectively. Cardioplegic solution, at a temperature of 10°c, 
is introduced through the aortic cannula at a pressure of 80cm 
H2o. Three way taps (T) can be closed off with removal of the 
cannulas as a separate unit to allow the hearts to be stored 
separately. 
ii) Solutions 
Modified Krebs-Henseleit buffer (mmol/1 NaCl - 118.5, NaHC0 3 -
25, KCl - 4.75, KH 2Po4 - 1.185, MgS04 - 1.19, CaCl2 - 1.25, 
Glucose 11), oxygenated with 95%02 5%co2 , was used to 
perfuse the hearts at 37°c (Krebs and Henseleit, 1932). The 
solution was made up from stocks (50 ml/1 of 692.30 g/1 NaCl; 
50 ml/1 of 210.50 g/1 NaHco 3 ; 10 ml/1 of 35.40 g/1 KCl; 10 ml 
of 16.13 g/1 KH 2Po4 ; 10 ml of 29.33 g/1 Mgso 4 .7H2o; 5 ml of 
36.75 g/1 CaC1 2 .2H20). Before the addition of calcium 
chloride, the solution was gassed with 95%0 2 5%co 2 to prevent 
the precipitation of calcium phosphate. 
Cardioplegic solutions were made fresh each day, gassed with 
95%02 5%Co2 during preparation. All solutions were filtered 
through filters of 5.0 µm and 0.8 µm (Millipore Corporation, 
Bedford, MA, USA) to remove large particles. This is required 
to prevent vasoconstriction induced by particles larger than 
10 µm in diameter to ensure adequate coronary flow on 
reperfusion of the heart (Hearse et al., 1985). 
iii) Experimental procedure 
Male Long-Evans rats were used, weighing between 280 and 420 
grams. Diethyl ether was used to anaesthetise the animals and 
200 i.u. of heparin injected into the exposed femoral vein. 
The hearts were excised and arrested in cold Krebs - Henseleit 
buff er ( about 4°C) . The aorta was cannulated, and retrograde 
perfusion through the aorta immediately initiated. The 
coronary sinus was incised to allow drainage of the coronary 
circulation. The pulmonary veins were then cannulated. The 
heart was briefly perfused through the left atrium to ensure 
correct cannulation and then allowed to stabilise in the 
Langendorff mode for ten minutes, after which the system was 
switched over to perfusion in the working mode. 
Functional measurements ( see below) were taken at the two, 
five and ten minute intervals in the working heart mode. The 
hearts were then arrested by the introduction of 10 ml cold 
cardioplegic solution through the aortic cannula, after the 
perfusion lines had been closed. 
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The hearts were maintained in an arrested state for three 
hours. Clinical procedures were simulated in one of the 
following ways, depending on the protocol of the specific 
experiment: 
- Simple storage (single dose) 
The hearts were arrested with 10 ml cardioplegic solution 
and stored at 10°c for the three hour arrest period. 
- Multiple dose infusions (multidose) 
The hearts were initially arrested with 10 ml cold 
cardioplegic solution, and thereafter flushed with 6 ml cold 
cardioplegic solution every thirty minutes over the three hour 
arrest period, while stored at 10°c. The coronary effluent 
from each flush was collected. 
After the three hour period of arrest, the hearts were 
reperfused in the Langendorff mode for 10 min. The coronary 
effluent was collected and the volume determined. Samples from 
the total volume of effluent were taken. This was followed by 
10 minutes perfusion in the working mode, during which the 
functional measurements were repeated. The hearts were freeze-
clamped at the end of the experiments using Wollenberg tongs, 
and the tissue subsequently freeze-dried. 
iv) Functional measurements 
Measurements in the working heart mode included 
Aortic output the output through the aortic line per 
minute at a pressure of 100 cm H2o, expressed as ml/min. 
- Coronary flow - the output from the coronary circulation, 
expressed as ml/min. 
- Heart rate - recorded via the pressure transducer, expressed 
as beats/minute. 
- Aortic pressure - systolic and diastolic pressures recorded 
from the aortic pressure trace. 
From the above measurements, other variables were calculated. 
These included: 
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- Cardiac output= Aortic output+ Coronary flow (ml/min) 
- Stroke volume= Cardiac output/Heart rate (ml) 
Functional measurements obtained during the post-ischaemic 
working heart period after 20 min reperfusion (10 min non work 
+ 10 min work) were expressed as a percentage of their 
individual pre-ischaemic control values taken at 10 min work. 
v) Biochemical analyses 
Samples of the post-ischaemic coronary effluent from the 
hearts when perfused in the Langendorff mode were collected, 
as was the 6 ml coronary effluent from each flush of 
cardioplegic solution. Simple biochemical analyses were 
performed on these samples, and on the freeze-dried heart 
tissue. 
The results for the coronary effluent samples are expressed as 
per 6 ml sample reflecting total washout from the heart, while 
those from post-ischaemic reperfusion are expressed as per ml 
per minute, derived from the total volume collected in the 10 
minute reperfusion period. 
Results are expressed as per gram wet weight of the heart, 
which was determined from the body weight of the rat using the 
following relationship: 
Wet Heart Weight= (Rat Wt+ 75.18)/359.71 
(derived from previous correlations for the laboratory strain 
- private communication - 0. Bricknell) 
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a) Lactate dehydrogenase 
Lactate dehydrogenase (LDH) is the enzyme responsible for the 
conversion of lactate to pyruvate during aerobic conditions, 
and the reverse reaction during hypoxia. There are five LDH 
isoenzymes, and the rate of release of these enzymes into the 
blood stream is an indication of the degree of myocardial 
injury (Hearse et al., 1973; Hearse and Humphrey, 1975). 
The LDH concentrations of the coronary effluent samples were 
determined using the method according to Bergmeyer and Bernt 
(1963). Spectrophotometric measurements were made when the 
enzyme was activated in the presence of NADH, pyruvate, KH2Po4 
and NaH2Po4 at a wavelength of 340 nm. 
LDH 
Pyruvate + NADH2 
The following cocktail was made: 
Stock 
KH 2Po4 76 mmol/1 









The composition of the phosphate buffer gives a pH of 7.5. 
0.5 ml sample was added to 1 ml cocktail and read at 340 nm 
(Beckman Model 42 Clinical Analyzer, Beckman Instruments Inc., 
Irvine, California). 10 readings were made at intervals of 10 
seconds at 37°c and the mean difference in optical density 
calculated (80D). The calculation was 
(80D)/min * 5053 * 0.419 * total vol = mUnits LDH/gm/ml 
heart weight sample vol 
where 5053 is the extinction coefficient for 1 mU/ml LDH at 
25°c and 0.419 is the correction for the assay at 37°c. 
The results for post-ischaemic LDH were expressed as 
milliunits per gram wet weight per minute (mU/gm/min). The 
results for the samples obtained with flushing were expressed 
as milliunits per gram wet weight yer 6 ml flush (mU/gm/6 mil. 
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b) Lactate 
The lactate concentration 1n the coronary effluent was 
determined by the method of Hohorst (1963), based on the 
reaction: 
LOH 
Lactate+ NAO+ # Pyruvate + NADH 2 
The difference in the extinction at 340 nm was measured. 
A cocktail mixture was 
hydrazine, 2 mmol/1 EDTA, 
with 2N NaOH): 
made up with a buffer (160 mmol/1 
400 mmol/1 glycine - pH 9. 3 - 9. 5 
Buffer 
NAO 1% (w/v) 
Distilled H2o 




0.2 ml sample was ~dded to 2.8 ml cocktail per cuvette. Blanks 
and standards at the appropriate concentrations (1 mmol/1 
lactate standard) were run. 
The absorbance at 340 nm was read (Beckman DU-7 
Spectrophotometer, Beckman Instruments Inc., Irvine, 
California), after which 10 µl LOH was added to each cuvette, 
and mixed. The absorbance was measured after approximately 1 
hour at 340 nm, and again every ten minutes until the values 
were stable. The difference in optical density (600) was 
determined. The calculations were 
[60D (sample) - 60D (Blank)J/0.414 = mmol Lactate/ml 
where 0.414 is the extinction coefficient for 200 µl of 
1 mmol/1 lactate. The results for post-ischaemic lactate were 
expressed as µmol per gram wet weight per minute 
(µmol/gm/min). The results for the samples obtained with 
flushing were expressed as µmol per gram wet weight per 6 ml 
flush (µmol/gm/6 ml). 
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c) Adenosine triphosphate and creatine phosphate 
The ATP and CP contents of the hearts were determined from the 
freeze dried tissue. The perchloric acid (PCA) extraction 
method was used. 
20-25 mg of powdered freeze-dried tissue was added to 1. 2 ml 
of cold 5% PCA. The mixture was immediately homogenised for 
15-30 secs while still on ice. The samples were then spun 
using a Sigma 202MK centrifuge at 5000 rpm for 10 min at 4°c. 
1 ml of supernatant was placed in Eppendorf tubes, and the 
acid neutralised to a pH of 6. 5 - 7. 5 with the addition of 
neutralising solution (200 mmol/1 Tris, 40% (w/v) KOH and 
saturated with KCl), using 5 µl Universal indicator. The 
sample was allowed to precipitate for 10 min, and then 
centrifuged for 5 min at 5000 rpm. The supernatant fractions 
were decanted and frozen until assayed. 
The dilution factor due to neutralising was calculated: 
F = [1.2 ml (PCA) x total volume]/wt (g) 
where Total volume neutralising volume + volume for 
neutralising (1 ml) + 5 µl Universal indicator 
The ATP and CP of the samples from the heart tissue were 
determined according to the method of Lamprecht and 
Trautschold (1963) based on the breakdown of glucose to form 
glucose 6-phosphate (G 6-P): 
Creatine phosphokinase 
CP + ADP # ATP+ creatine 
Hexokinase 
ATP+ Glucose~ ADP+ G 6-P 
Glucose 6-phosphate dehydrogenase 
G 6-P + NADP 6-Phosphoglucono-o-
lactone + NADPH+ + H+ 
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The following cocktail was made: 
Stock Cocktail (Per cuvette) 
MgC1 2 1 mmol/1 0.1 ml 
Tris 0.2 mmol/1 (pH 7.5) 1.0 ml 
NADP 1% (w/v) 0.1 ml 
Glucose 100 mmol/1 0.05 ml 
H2o 1. 65 ml 
0.1 ml sample and 5 µl G6PDH (10 mg/ml) was added to 2.9 ml 
cocktail per cuvette. The extinction at 340 nm was read 
(Beckman DU-7 Spectrophotometer, Beckman Instruments Inc., 
Irvine, California). 5 µl hexokinase (10 mg/ml) was added to 
each cuvette, and the extinction at 340 nm read after ten 
minutes when stable. 
The difference in. optical density was obtained and used to 
calculate ATP concentration: 
(~OD - blank)/0.414 * F = µmol/gm dried weight 
For the determination of CP levels, 0.05 ml of 10 mmol/1 ADP 
was added to the cuvette. After 10 min, a reading at 340 nm 
was taken for the baseline reading of CP. 10 µl Creatine 
phosphokinase (5 mg/ml) was added, and a reading taken after 
30-60 min. 
The above calculation was used. 
High energy phosphate levels were expressed as µmol/gm fresh 
weight, where the results for dried weight were divided by a 
factor of 5. 
Control levels of ATP and CP were obtained from hearts 
following the above protocol clamped after 10 min work before 
arrest. 
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vi) pH, p02 , pC02 
These variables were determined for the cardioplegic solutions 
and the effluent samples collected during arrest. An 
Instrumentation Laboratory System 1302 pH/Blood gas Analyzer 
(Milan, Italy) corrected for measurements at 10°c was used. 
Oxygen content of the solutions was determined using the 
solubility coefficient (a) of oxygen in saline solution at 
10°c equilibrated at a po 2 of 760 mmHg: 
Oxygen content/ml= a* p0 2/760 mmHg 
where a= 37 ml o 2 per litre of solution (Altman and Dittmer, 
1971). 
The results were expressed as ml 0 2/6 ml. 
The oxygen uptake by the hearts during arrest per 6 ml flush 
of cardioplegic solution was calculated as: 
o 2 uptake= (po 2 cardioplegic solution 
- po 2 coronary effluent) * o 2 content 
The results were expressed as ml o 2/gm wet weight/6 ml. 
The pH at different temperatures was measured to obtain 
Rosenthal correction factors for the different solutions. 
With a reduction in temperature of a solution, there is an 
increase in pH and in the po2 . The relationship between a 
change in temperature (from x 0 c to y°C) and pH is expressed as 
pHy = pHx + (x-y) * R 
where R = Rosenthal correction factor 
= 0.017 (water) 
= 0.0147 (blood) 
vii) Titration curves and buffering capacities 
Titration curves for the cardioplegic solutions were 
determined by adding 500 µl aliquots of lN HCl to the solution 
kept at 10°c. 
The buffering capacities for the solutions were obtained by 
determining the instantaneous (derivative) slope of the 
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titration curves. Buffering capacity was expressed as mmol 
HCl/1/pH. 
viii) Statistical analyses 
a) Exclusion criteria 
In the pre-ischaemic control period in the working mode, the 
following values were used to discard hearts: 
30 ml/min < Aortic output < 60 ml/min 
12 ml/min < Coronary flow < 22 ml/min 
Heart rate< 200 beats/min, or irregular rhythm 
In the post-ischaemic period, any heart whose coronary flow 
increased significantly (50% greater than pre-ischaemic value) 
was excluded, because of the probability of a left atrial 
leak. 
Extreme observations or "outliers" based only on post-
ischaemic aortic ~utput, were tested by Dixon's criteria for 
testing extreme observations in a single sample (Snedecor and 
Cochran, 1981). With this test, the extreme values of a sample 
size n, given in ascending order from 1 .. n, are tested 
according to the relationship 
(Xn - Xn_ 1 )/(Xn - X1 ) or (X 2-X 1 )/(Xn-Xl) 
The levels for significance are read off a table of Dixon's 
criteria. A significance value of p<0.05 was used. 
The entire data set of these hearts was then excluded from 
further analysis in order not to distort the mean by inflating 
the error variance due to major experimental errors. In each 
sample group, 1 to 2 hearts were excluded. 
b) Determination of significance 
Pre- and post-ischaemic functional values were compared for 
significance using a three-way analysis of variance. This test 
depends on 
observations 
an assumption of common variance amongst 
within each treatment group, which was not 
observed in this study. Therefore, in specific comparisons of 
interest, necessary adjustments for the violation of common 
variance was made. Pairwise comparisons of means using no 
41 
assumption of common variance was performed using t-statistics 
with a nominal level of significance set at p<0.05. 
A consequence of multiple comparisons is that a greater degree 
of significance may be found than actually exists. However, 
the number of significant comparisons obtained was a large 
fraction of the total number of comparisons studied, too large 
to be explained by probability. 
Multiple comparison t-tests were used to establish 
significance of differences in measured biochemical values 
during and after arrest. Values obtained during arrest were 
compared between groups and within groups for differences. The 
average of the variables measured for each group were 
compared, with means for all samples per group taken. 
Significance was taken at p<0.05. 
All results are expressed as means ± standard error of the 
mean ( SEM). 
c) curve fitting 
Regression lines to determine the slopes of the pH/temperature 
curves, and the sigmoid titration curves were fitted using 
GraphPAD™ computer software (ISI Software, Philadelphia, 
Penn. , USA) . 
ix) Chemicals 
Enzymes were obtained from Boehringer Mannheim GmbH, W. 
Germany. L-Histidine (free base) was obtained from Sigma 
Chemical Company, St Louis, MO, USA. Bretschneider's HTK 
cardioplegic solution was obtained from Dr. F. Kohler Chemie 
GmbH, Alsbach, W.Germany. 
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IV. RESULTS AND DISCUSSION 
A. Glucose in the ST solution - single dose and multidose 
a) Introduction 
Energy levels in the ischaemic myocardium are thought to be a 
crucial determinant of recovery. The energy demands of the 
arrested heart depend mainly on maintenance of the ionic 
gradients and cellular structure, and myocardial wall tension 
(Buckberg, 1979). One means of maintaining energy levels in an 
arrested heart is to increase production via anaerobic 
glycolysis by adding glucose to the cardioplegic solution. 
Glucose is a naturally occurring substrate and is routinely 
included in the K-H buffer for perfusion of isolated hearts. 
It has many other beneficial effects which may aid ischaemic 
arrested hearts. 
The inclusion of glucose in a cardioplegic solution has been 





Buckberg, 1979; Conti and Kao, 1983; Guilbeau et 
de Wit et al., 1988). An increased rate of 
1s associated with an increased intracellular 
proton concentration and lactate accumulation which may be 
deleterious to the ischaemic cells (Neely et al., 1975). The 
adverse effect of glucose in a cardioplegic solution has also 
been attributed to the build up of the waste products of 
glycolysis which are not washed out of the cell (Hearse et 
al., 1978b).With the reduction in temperature of cardioplegic 
arrest, the expenditure of energy is decreased, and usage of 
intrinsic substrate stores may meet the reduced metabolic 
requirements. The deleterious effects of glucose inclusion may 
therefore outweigh the benefits under these circumstances. 
However, intermittent flushing of the cardioplegic solution 
with the provision of a substrate at a low temperature may be 
desirable. Low flow ischaemia with washout of accumulated 
metabolites has been shown to be advantageous (Neely et al., 
1975) and the use of mul tidose administrations of a 
cardioplegic solution may utilise this effect. 
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b) Experimental Procedure 
11 mmol/1 glucose was added to the basic ST solution as this 
is the concentration used in the modified K-H solution. This 
concentration in the perfused rat heart has been shown to be 
optimal for glucose transport into the cell, and subsequent 
oxidation (Opie et al., 1962). 
Comparisons between the preservative qualities of the standard 
solution with and without glucose in a single dose protocol 




i) Single dose cardioplegia followed by 3 hrs global ischaemia 
at 10°c with St Thomas' No 2 versus St Thomas' No 2 + Glucose 
a) Functional recoveries 
Measurements taken for heart rate, aortic output and coronary 
flow during the working heart mode prior to arrest were 
compared for differences between groups. No significant 
differences were found (Table 3) (Aortic pressures are not 
shown as these did not reflect any differences between 
groups). 
The percentage recovery of aortic output after 20 min 
reperfusion ( 10 min non-work followed by 10 min work) after 
arrest with the ST+Glucose cardioplegic solution was slightly 
greater than that after arrest with ST (65.9 ± 2.9 % compared 
to 57.4 ± 5.2 %) (Table 3). Cardiac output was similarly 
improved. These ~hanges were not significant. There was, 
however, a significant increase in stroke volume with the 
inclusion of glucose ( 76. 2 ± 3. 2 % versus 58 .1 ± 4. O % 
p<0.01). This may have been due to the combination of improved 
cardiac output and a lower heart rate with ST+Glucose. 
However, overall functional performance of the hearts was not 
greatly affected by the inclusion of glucose in the 
cardioplegic solution. 
b) Post-ischaemic LOH washout 
During the first ten minutes of reperfusion in the Langendorff 
mode, a significantly greater washout of LOH was seen with 
hearts arrested with 
with ST, with 66.4 ± 
respectively (p<0.02) 
ST+Glucose compared to those arrested 
7. 7 mU/gm/min and 37. 7 ± 7. 5 mU/gm/min 
(Table 4). LOH loss is thought to 
reflect membrane integrity (Hearse et al., 1973; Hearse et 
al., 1975). Glycolytic ATP has been associated with membrane 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































et al., 1984) and prevention of leakage of LOH (Hearse et al., 
1976). However, the presence of glucose in the ST solution 
after single dose cardioplegia increased LOH washout. 
c) Post-ischaemic lactate washout 
Lactate efflux during the first ten minutes of reperfusion in 
the Langendorff mode showed no significant differences between 
the two groups indicating similar rates of glycolysis, 
although lactate efflux after arrest with ST+Glucose tended to 
be higher. Lactate was produced both during ischaemia and 
reperfusion, as both groups were reperfused with 11 mmol/1 
glucose in the KH solution. 
d) High energy phosphate levels in tissue 
Values of 3.91 ± 0.25 µmol ATP/gm fresh weight and 5.05 ± 0.45 
µmol CP/gm fresh weight were obtained for control hearts 
clamped after the initial working period {Table 5). 
The tissue ATP levels at the end of 20 min reperfusion were 
significantly depressed when compared to control ATP values, 
with 2.61 ± 0.37 µmol/gm fresh weight for ST and 2.73 ± 0.43 
µmol/gm fresh weight for ST+Glucose {p<0.04) {Table 5). There 
was no difference between the ATP tissue values of the two 
experimental groups. 
The levels of CP after arrest and reperfusion for both groups 
were not significantly different from control values or from 
each other {Table 5). 
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Table 5: Means ± sem of tissue levels of adenosine 
triphosphate (ATP) and creatine phosphate (CP) of control 
hearts clamped after 10 minutes work before arrest, and of 
arrested hearts after 20 minutes reperfusion. Comparison of 
hearts arrested with St Thomas' Hospital cardioplegic solution 
No. 2 without (ST) and with llmmol/1 glucose (ST+G) and stored 
for 3 hours at 10°c ( single dose) or flushed intermittently 
with 6ml cardioplegic solution (multidose). 
ATP CP 
(µmol/gm) (µmol/gm) 
Control 3.91 ± 0.25 5.05 ± 0.46 
(n=6) 
Single dose 
ST 2.61 + 0.37 * 4.52 ± 0.10 
(n=7) 
ST+G 2.73 ± 0.14 * 3.85 ± 0.34 
(n=lO) 
Multidose 
ST 3.22 ± 0.14 * 4.99 ± 0.34 
(n=9) 
ST+G 3.39 ± 0.08 4.90 + 0.28 
(n=8) 
* p<0.04 vs control 
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ii) Multidose cardioplegia 
intermittent infusions every 
without glucose 
(initial arrest fallowed by 
30 min over 3 hrs) with and 
a) Functional recoveries 
The effects of glucose in the ST cardioplegic solution using a 
multidose protocol over a 3 hour period were tested. The 
cardioplegic solutions were intermittently introduced at 30 
min intervals. 
Pre-ischaemic values of functional parameters were not 
significantly different between groups (Table 3). 
ST+Glucose in a multidose protocol resulted in a greatly 
improved contractile performance on reperfusion when compared 
to ST. Aortic output and cardiac output were significantly 
greater (p<0.025), with an average of about 90% recovery of 
pre-ischaemic function for all parameters (Table 3). 
b) LDH washout during and after arrest 
During arrest, washout of LDH was slightly 
ST+Glucose multidose group, although there 
decline over time in both groups (Figure 
greater in the 
was a gradual 
2) . Average LDH 
washout showed no significant differences between groups 
(Table 4). 
Post-ischaemic LDH washout was, however, higher in the ST 
multidose group although not significantly so (Table 4). 
Glucose may have had a slightly beneficial effect on membrane 
integrity on reperfusion. 
c) Lactate efflux during and after arrest 
The mean lactate efflux with each cardioplegic reinfusion did 
not differ significantly between the ST and ST+Glucose groups. 
This is shown in Figure 3. There was an initial high level of 
lactate washout in both groups, which was slightly greater 
with ST+Glucose. This was possibly due to a slightly higher 
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Time (min) 
~ST+G 
Fig. 2. Means± sem of washout of lactate dehydrogenase (LDH) 
during arrest per 6ml flush of cardioplegic solution. 
Comparison of hearts arrested with St Thomas' Hospital 
cardioplegic solution No. 2 without (ST, n=9) and with 11 
mmol/1 glucose ( ST+G, n=8). Arrested hearts were 
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30 60 90 120 150 
Time (min) 
~ST+G 
Fig. 3. Means ± sem of washout of lactate during arrest per 
6ml flush of cardioplegic solution. Comparison of hearts 
arrested with St Thomas' Hospital cardioplegic solution No. 2 
without (ST, n=9) and with 11 mmol/1 glucose ( ST+G, n=S) . 
Arrested hearts were intermittently flushed with cardioplegic 
solution over 3 hours at 10°c. 
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up of inhibitory end products. The glycolytic rate appeared to 
remain fairly constant for the remainder of the ischaemic 
period with a tendency for greater lactate efflux with the 
glucose-containing cardioplegic solution. This was reflected 
in the average washout of lactate with 1.87 ± 0.11 µmol/gm/6ml 
for ST and 2.49 ± 0.16 µmol/gm/6ml for ST+Glucose (p<0.002) 
(Table 4). 
Post-ischaemic lactate washout in the initial 10 min 
reperfusion in the Langendorff mode after mul tidose usage of 
ST+Glucose was high (1.76 ± 0.32 µmol/gm/min), more than 
double that after arrest with multidose ST (0.67 ± 0.08 
µmol/gm/min) (p<0.03) (Table 4). 
d) High energy phosphate levels in tissue 
Similar levels of tissue ATP after 20 min reperfusion with 
multidose ST+Glucose was found compared to that with multidose 
ST (Table 5). However, in comparison with control values there 
was a significant decrease in the ST group (p<0.04) but not in 
the ST+Glucose group. CP was close to control values for all 
groups (Table 5). 
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iii) Comparison of multidose and single dose cardioplegia 
Recovery of aortic output, cardiac output and stroke volume 
improved from single dose to multidose usage {Table 3) by at 
least 15-20% with both ST and ST+Glucose solutions. All were 
significant improvements (p<0.05). 
There was a detrimental effect of multi dose cardioplegia as 
shown in an increased washout of LDH on reperfusion compared 
to hearts with single dose cardioplegia ( Table 4) , possibly 
because of greater mechanical abrasion of the cells by 
intermittent reintroduction of fluid. However, the overall 
benefits of multi dose cardioplegia were apparent, while the 
inclusion of glucose with this protocol had an additive effect 
on recovery of the arrested hearts. This may be attributed to 
prevention of the accumulation of harmful end products, 
thereby allowing more efficient metabolism of the glucose 
administered intermittently. 
iv) Dose response curve during multidose cardioplegia 
The inclusion of glucose in the ST solution was tested at 
various concentrations with multidose flushing. The dose 
response curve for aortic output and cardiac output thus 
obtained is illustrated in Figure 4. These curves indicate 
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-~ 
Glucose (mmo 1/1) 
* Aortic output 
+ Cardiac output 
Fig. 4. Dose response curve for glucose added to the St 
Thonas' Hospital cardioplegic 
concentrations of O mmol/1 ( n=9) , 
( n=4) , 9 mnol/1 ( n=4) , 11 mmol/1 
solution No. .., .:. . Glucose 
5 mmol/1 ( n=4) , 7. 5 mmol/1 
( n=S) , 15 mmol/1 ( n=9) and 
20 mmol/1 (n=4) were compared. The arrested hearts were 
intermittently flushed for 3 hours at 10°c. Values for 
percentage recovery of aortic output and cardiac output are 
shown as means± sem. 
* p<0.005 vs O mmol/1, 20 mmol/1 
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d) Discussion 
i} Role of glucose in ischaemia 
The benefits of glucose in an ischaemic heart include enhanced 
anaerobic metabolism (Opie, 1989c), inhibition of ischaemic 
contracture (Owen et al., 1990), reduced K+ efflux (Weiss and 
Lamp, 1987), decreased fluctuation in membrane potential with 
possible antiarrhythmic effects (Manning and Hearse, 1984; 
Bernier and Hearse, 1988), prevention of cellular swelling by 
exertion of an osmotic effect (Rink, 1984), preservation of 
membrane integrity (Bricknell and Opie, 1978), inhibition of 
enzyme release ( Hearse et al. , 1976) , and action as a free 
radical scavenger (Hearse and Humphrey, 1975; Hess and Manson, 
1984). When glucose is present during an ischaemic or arrest 
period, the glycolytic ATP produced may aid in the prevention 
of ca 2+ overload and contracture in the cells by enabling 
uptake by the ATP dependent ca 2+ pumps of the SR as well as 
prevention of ca2+ overload by activation of the Na+;K+ pump 
(Bers and Ellis, 1982). Glucose can act as a free radical 
scavenger directly, as well as inhibiting the formation of 
free radicals by acting as a substrate for ATP production with 
prevention of ca2+ overload, and consumption of the precursors 
of ATP. 
Because of the associated benefits of glucose during 
ischaemia, the addition of this substrate to cardioplegic 
solutions has been proposed. However, it has been suggested 
that the stores of glycogen in the heart are sufficient for 
the supply of energy with a reduced metabolic rate (Lell and 
Buttner, 1983). Glycogen acts as a primary substrate for 
glycolysis, as it is the main storage form of energy in the 
cell, but its breakdown is inhibited by the accumulation of 
metabolites (Opie, 1989c).It has also been shown that in the 
absence of glucose, a high glycogenolytic flux is ineffective 
in preventing ischaemic contracture (Owen et al., 1990). It is 
postulated that this may be because glycogen is situated close 
to the SR, whereas glucose introduced to the cells is closer 
to the sarcolemma, where ATP is required for maintaining 
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homeostasis of the cell membrane. The metabolites of 
glycolysis can also be removed from the cytosol more easily. 
ii) Glucose in cardioplegic solutions 
The above results indicate that the inclusion of 11 mmol/1 
glucose in the ST solution when used in a single dose protocol 
is not disadvantageous to the heart, with an indication rather 
of slightly improved recovery. This may be related to an 
increased energy production as well as other actions of 
glucose. However, washout of lactate after arrest was similar 
in the two groups. 
Upon cessation of flow in the arrested hearts, glycolysis is 
rapidly inhibited, with the accumulation of metabolites 
(Rovetto et al., 1975). The small amount of glucose taken up 
from the cardioplegic solution would not greatly affect the 
rate of energy production to a level resulting in increased 
functional recovery, whereas the slight increase in the 
accumulated waste products may have harmed the cells. This may 
have been reflected as membrane damage and subsequent enzyme 
loss, with a higher washout of LOH in the ST+Glucose group. 
The benefits of glucose may therefore not have been apparent 
under these conditions. 
These results are in contrast to the results of Hearse et al. 
( 1978b), which would appear to indicate that glucose in a 
cardioplegic solution is harmful to the arrested heart. A 
single infusion of a ST-like solution (mmol/1 Na+ 115, K+ 16, 
ca 2+ 1. 2, Mg 2+ 16) with a greater bicarbonate concentration 
(25 mmol/1) and gassed with 95%02 5%C02 was used. Glucose was 
added at concentrations from 0-50 mmol/1. The hearts were 
maintained at a temperature of 2s0 c for a period 70 minutes. A 
recovery of 59. 2 ± 5. 7% for aortic output with 11 mmol/1 
glucose, as opposed to 80.7 ± 2.4% without glucose was 
obtained. Similar trends for other functional parameters were 
observed. Further increases in the glucose concentration 
resulted in even lower recoveries. However, their study was 
conducted with hearts maintained at 2s 0 c as opposed to 10°c. 
With a lower temperature over a longer time period, it would 
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seem that glucose has no detrimental effect and may, in fact, 
aid the heart. This may have important consequences when 
considering longer term preservation, where the benefits of 
glucose may be more apparent. 
iii) Multidose cardioplegia and glucose 
With the multidose protocol, glucose in the ST solution led to 
greatly improved recoveries. With intermittent flushing, there 
is removal of accumulated metabolites, which allows more 
efficient metabolism of glucose without the associated 
deleterious effects. 
A regimen of multiple administrations of cardioplegic solution 
during cardio-pulmonary bypass has been found to be effective 
in other studies, with benefits including maintenance of 
arrest and hypothermia in the presence of noncoronary 
collateral flow, removal of harmful metabolites, replenishment 
of substrate, maintenance of an appropriate pH and prevention 
of oedema (Conti and Kao, 1983). 
In the presence of glucose, multidose cardioplegia may be 
especially beneficial, by removing metabolites which inhibit 
glycolysis and ensuring an optimal intracellular pH. Neely et 
al. (1975) suggested that the harmful effects of ischaemia are 
due as much to the lack of washout of harmful products as to 
the lack of substrate as a correlation between coronary flow 
and rates of glycolysis was found in the ischaemic heart. 
Inhibition of glycolysis occurs as the flow rate is decreased, 
with accumulation of metabolites and a decrease in ATP and CP 
levels. The relationship between washout of metabolites and 
recovery is thus emphasised. 
Other studies with mul tidose flushing have not clarified the 
role of glucose in a cardioplegic solution. Conti and Kao 
(1983) found that single dose administration of Tyer's 
cardioplegic solution (mmol/1 Na+ 139, K+ 25, ca 2+ 0.9) at a 
temperature of 32°c did not result in any measurable recovery, 
while mul tidose cardioplegia showed great improvements, both 
with and without glucose. However, Guilbeau et al. (1984) 
looked at the effect of single or intermittent perfusions of a 
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cardioplegic solution (mmol/1 Na+ 115, 
28°c with or without 27.8 mmol/1 
K+ 16, ca 2+ 1.2) at 
glucose. Multidose 
cardioplegic protection was found to reduce lactic acid 
accumulation and improve functional recoveries, al though no 
differences were seen with the inclusion of glucose. De Wit et 
al. ( 1988) found that the addition of glucose to a 
cardioplegic solution gassed with 95%02 5%co2 did not increase 
the degree of recovery of the hearts. However, the amount of 
glucose added to the solution was 2.5% of glucose plus 
insulin. In the dose response curve on the optimal 
concentration of glucose, it can be seen that this high a 
concentration (approximately 45-50 mmol/1) is deleterious. 
However, the use of 
ST+Glucose solutions 
a multi dose protocol with 





presence of glucose, with its putative role in preventing 
membrane damage, did not affect the washout of LDH in the 
multi dose group to a marked degree, and was associated with 
increased loss of LDH in a single dose protocol. 
LOH, which is lost from cells with membrane damage (Hearse et 
al., 1973; Hearse et al., 1975) is thought to accumulate in 
the interstitial spaces during ischaemia from which rapid 
washout occurs on reintroduction of fluid. Mechanical forces 
may add to the efflux of LDH, both from the interstitial 
space, and by damage to the cell membranes (Kao and Magovern, 
1986) . This may result in an increase in enzyme loss, and 
other deleterious effects associated with "leaky" membranes. 
The endothelial cells particularly may be damaged by this 
procedure as these are the primary barrier between the 
myocytes and the vascular system. 
The use 
pressure 
of a solution which has a 
than the intracellular and 
lower colloid osmotic 
interstitial fluids may 
also increase LDH washout with multi dose cardioplegia. There 
may be a continual removal of enzymes from the inters ti tium 
down an osmotic gradient allowing further leakage. With no 
maintenance, there is no gradient between the interstitium and 
the vascular system, slowing the rate of LOH washout. However, 
in the absence of washout of end products of metabolism, the 
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accumulated products may harm the cells and lead to reduced 
functional recovery. With the addition of glucose, there is 
greater accumulation of these end products, which may explain 
the greater washout of LDH on reperfusion after single dose 
arrest with ST+Glucose. 
iv) Energy production with glucose 
It is proposed that an increase in glycolytic ATP production 
as a result of the inclusion of glucose is beneficial, as a 
correlation between high energy phosphate content with 
recovery after an ischaemic period has been found (Neely et 
al., 1973; Hearse et al., 1974; Nayler et al., 1979; Bricknell 
et al., 1981; Lazar et al., 1980). 
In our results, little correlation was observed between high 
energy phosphate measurements and recovery. However, these 
measurements reflect the ATP levels of the myocardium after 20 
min reperfusion, by which time energy stores have been 
partially regenerated. Hence this measurement is not a 
reflection of the maintenance of high energy phosphate stores 
during arrest. 
The total lactate content of the samples of cardioplegic 
solution flushed through the heart during arrest represents a 
minimum rate of about 5.61 µmol ATP/gm wet weight produced for 
ST per 30 min period (or 0.19 µmol ATP/gm wet weight/min) (6 
mol ATP/2 mol lactate/mol glycogen in the absence of exogenous 
substrate). For the ST+Glucose group, this ranges between a 
minimum of about 4.98 µmol ATP/gm wet weight per 30 min (about 
O .17 µmol ATP /gm wet weight/min) ( only glucose used - 4 mol 
ATP /2 mol lactate/mol glucose) with a maximum of about 7. 4 7 
µmol ATP/gm wet weight per 30 min (about 0.25 µmol ATP/gm wet 
weight/min) (all from glycogen). Thus the inclusion of glucose 
did not seem to alter the turnover of this pathway. 
The minimum rate of glycolysis which prevents the development 
of contracture in a model of low flow ischaemia would appear 
to be about 2 µmol/gm fresh weight/min (Owen et al., 1990). To 
maintain this rate, it is necessary to allow glycolysis to 
continue by the provision of glucose, and to prevent its 
inhibition by the build up of waste products. This would be 
provided for by multiple infusions of cardioplegia during the 
arrest period. However, in the arrested heart at 10°c, the 
metabolic rate is much lower and the ATP thus produced appears 
to be sufficient to maintain cellular processes. 
However, in estimating minimum rates of glycolysis and 
subsequent rate of ATP production from the washout of lactate 
during arrest, errors will occur because of several factors. A 
certain amount of the available glucose may have been utilised 
by the Krebs cycle and oxidative phosphorylation because there 
was a certain amount of oxygen available in the solution open 
to atmosphere (po 2 approximately 150 mmHg). The production of 
ATP from this glucose will not be reflected as lactate. The 
amount of ATP derived from glucose is therefore 
underestimated. However, assuming 
phosphorylation with both ST and 
equal rates of oxidative 
ST+Glucose, any additional 
energy derived from glucose appears to confer a significant 
degree of protection by improving functional recoveries. 
Not all the lactate is flushed out of the hearts each time and 
there may be an accumulation in the cells as well as in the 
interstitial fluid. Only 6ml cardioplegic solution is flushed 
through the heart with each reinfusion, and while the infusion 
pressure ( 80 cm H20) is thought to be sufficient to ensure 
perfusion of the whole vascular bed, the amount of solution 
flushed through may not remove all the accumulated lactate. 
The use of more solution to flush the heart may, however, be 
damaging because of abrasion and disturbance of the 
endothelial cells (Kao and Magovern, 1986). 
Increased reperfusion lactate in the ST+Glucose group may be a 
reflection of either 
1) higher tissue accumulation during ischaemia or 
2) higher flux rates on reperfusion. 
While the amount of ATP produced during arrest, and that 
present in the tissue after 20 min reperfusion may not show 
any significant trends, the levels of ATP measured may be an 
indication of the preservation of the mechanisms of ATP 
production. Lazar et al. ( 1980) suggests that the ischaemic 
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heart develops a defect in its oxidative metabolic pathways 
which determines the recovery of ATP production upon 
reperfusion. The mitochondria might be damaged by lactate 
accumulation, ca2+ influx on reperfusion and free radical 
activity. In addition, there is a loss of nucleotides from the 
cells during ischaemia which are needed for the regeneration 
of ATP (Reimer et al., 1981). The presence of glucose may have 
improved the ability of the myocardium to regenerate its 
stores of ATP. While actual levels of ATP during and after 
ischaemia may not be critical, an improved recovery is 
correlated with slightly higher ATP levels. 
CP levels are rapidly restored after an ischaemic period 
(Taegtmeyer et al., 1985) unless the mechanisms for 
regeneration are damaged, which is an indication of 
irreversible injury. All the hearts did recover to a certain 
extent, thus it was not expected that CP levels would be low 
after 20 min reperfusion. The measurements were not 
significantly different from control values. 
v) Optimal glucose concentration of the ST solution 
The results of the various studies of the inclusion of glucose 
in the ST and other cardioplegic solutions are conflicting, 
but it would appear that there is an optimum concentration of 
glucose, outside the range of which it is deleterious. This is 
also suggested by Bernier and Hearse (1988), in their studies 
on reperfusion of an ischaemic area with a glucose-containing 
solution. Outside of these concentrations, glucose may indeed 
be harmful to the heart, as found by Hearse et al. (1978b). 
This is corroborated by the dose response curve for glucose in 
the ST solution. An increasing glucose concentration may lead 
to excess intracellular proton and lactate accumulation, 
outweighing the advantageous effects of increased energy 
production. Glucose uptake into the cell is limited by 
transport rate across the membrane which is dependent upon the 
concentration. This rate is possibly saturated at excess 
concentrations, as may be other enzymatic reactions of the 
glycolytic pathway. The products of glycolysis accumulate with 
the initial high rate of the reaction at the onset of 
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ischaemia, and the enzymes cannot act to break down the 
accumulating glucose because the ATP pool is depleted. 
vi) Conclusions 
The addition of glucose to a solution used with a mul tidose 
protocol is recommended as this leads to greatly improved 
mechanical function on reperfusion of the isolated rat heart 
after 3 hrs arrest. 
There were, however, variables in the use of the solution, 
which was gassed with 95%02 5%co2 when made up (to prevent 
precipitation of calcium phosphate), but then left open to 
atmosphere. The po 2 and pH of the solution must have varied 
with time, and also with changes in temperature. These 
variables were not taken into consideration in these initial 
experiments and further studies were made to determine the 
exact contribution of these factors to the recoveries of the 
hearts. We wished to establish stable criteria for the use of 
the ST+Glucose solution with a multidose protocol, where the 
solution can be gassed, with possible improvements in 
recovery. 
The efficacy of the glucose containing ST solution for use in 
a single dose protocol may possibly be increased by further 
changes in the composition. These may include the addition of 
a buffer to counter the effects of an increased proton 
production associated with an increased rate of glycolysis. 
The presence of glucose may also lead to improved long term 




B. Oxygenation and pH of the ST+Glucose solution with 
multidose cardioplegia 
a) Introduction 
i) Oxygenation of a cardioplegic solution 
With cessation of coronary flow, oxygen supply to the 
mitochondria is suppressed, with a subsequent reduction in 
energy production. Although the metabolic rate is reduced with 
hypothermia and increased extracellular K+, the supply of 
oxygen in a cardioplegic solution may be beneficial by 
increasing energy production. The o 2 imbalance which develops 
in the myocardium over the ischaemic period can be met in part 
by intermittent reinfusions of an oxygen containing solution, 
while the co2 produced will be removed. This will also enable 
more efficient usage of glucose present in the ST+Glucose 
cardioplegic solution. 
In a solution open to atmosphere, the po 2 is about 150 mmHg. 
With a single dose protocol, any oxygen provided will 
presumably be rapidly consumed. The question is whether, with 
intermittent reinfusions of the cardioplegic solution, a 
higher po 2 would be more beneficial, and whether the myocytes 
do indeed utilise the additional oxygen. However, a 
disadvantage of a highly oxygenated solution with a multidose 
protocol may be an increased formation of oxygen free radicals 
at each reinfusion. The inclusion of oxygen at a high partial 
pressure is also associated with practical problems, where the 
simplest means of administration of a cardioplegic solution 
are preferred. Care must be taken to avoid the formation of 
gaseous emboli (Buckberg, 1979). The extra addition of oxygen 
in the face of these problems may not confer any additional 
protection to the myocardium. 
ii) pH changes with gassing of a solution 
Gassing with 100% o2 in the presence of bicarbonate produces a 
marked increase in the pH as all the co 2 in the solution is 
blown off. The change in pH thus elicited in the oxygenated 
solution may affect the recovery of the hearts. The presence 
of glucose may also intensify the development of intracellular 
acidosis by increasing glycolytic flux (Gevers, 1977). The 
optimal pH of a cardioplegic solution under such circumstances 
must be determined. 
Most surgeons maintain cardioplegic solutions at a pH of 7. 8 
at 10°c, because of 
alkalosis (Buckberg, 
the presumed advantageous effects of 
1979; Swan, 1984) which rest on 
extrapolation from the ectothermic strategy of acid-base 
management (Reeves and Malan, 1976; Swan, 1984). A large fall 
in intracellular pH is associated with long-term ischaemia 
(Cobbe and Poole-Wilson, 1980a), which is thought to be 
harmful to the tissue. However, experimental studies have 
shown the beneficial effect of a lower pH of a cardioplegic 
solution (Nugent et al., 1982; Bernard et al., 1985), linked 
to improved energy conservation. 
The adjustment of pH by a change in pco 2 is practically 
applicable becaus.e co2 is freely permeable through the cell 
membrane, has a rapid effect on intracellular pH, and the 
regulation of pco2 in solution is easy. co2 enters the cell 
rapidly, while the flux of H+ and Hco 3- is slow, thus 
respiratory acidosis exerts a greater effect than does 
metabolic acidosis ( Cingolani et al. , 1970; Nayler et al., 
1979). In conjunction with other gases, this manipulation may 
increase the effectiveness of the ST+Glucose cardioplegic 
solution. 
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b) Expermental Procedure 
The glucose-containing ST solution in a mul tidose protocol, 
was gassed with either 100% N2 or 100% o2 in order to 
determine the effect of oxygenation of a solution at a high 
pH. Oxygenation at a low pH was then tested, with the addition 




i) Multidose arrest with ST+Glucose gassed with 100% N2 or 
100% 02 
a) pH and p02 of the cardioplegic solutions 
The effect of oxygenation of the ST+Glucose cardioplegic 
solution was tested by gassing with 100%N2 or 100% o 2 . This 
displaced all other gases in the solutions, and made the pH 
alkaline with high or low po 2
1 s. The pH's and po 2 's of the 
solutions are shown in Table 6. In comparison, the ST+Glucose 
solution open to atmosphere had relatively low p02 's of about 
150 - 400 mmHg and pH's ranging from 7.3 to 8.0, depending on 
the time of sampling after the initial gassing with 95%0 2 
5%C02 . 
The pH of the 100% N 2 ST+Glucose solution was slightly lower 
than the 100% o 2 solution. 
b) Functional recoveries 
Pre-ischaemic control values were not significantly different. 
These are shown in Table 7, together with the values attained 
on reperfusion. (Aortic pressures are not shown as no 
significant changes were seen). 
Percentage recoveries of aortic output and cardiac output 
obtained when the ST+Glucose solution was gassed with 100% o 2 
were significantly greater than gassing with 100% N2 {p<0.05), 
with an overall increase of about 15%, although the pH's of 
the cardioplegic solutions were similar {Table 7). The 
presence of a high po2 was beneficial compared to an absence 
of oxygen at a high pH. 
c) pH of the coronary effluents 
The pH's of the coronary effluents from intermittent flushing 
tended to equilibration with the arterial cardioplegic 
solutions over time, from initial extracellular pH's of about 
7.4 (K-H). These trends are shown in Figure 5. Effluent pH is 
thought to reflect similar changes in intracellular pH as the 
proton gradient across the membrane is maintained by 
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Time (min) 
Fig. 5. Means± sem of pH's of the coronary effluent samples 
during arrest. Comparison of hearts arrested with St Thomas' 
Hospital cardioplegic solution No. 2 with 11 mmol/1 glucose 
gassed with 100% N2 (pH 9.07 ± 0.1, n=6), or 100% o2 (pH 9.3 ± 
o.os, n=S). Arrested hearts were intermittently flushed with 
cardioplegic solution over 3 hours at 10°c. 
* 
* 
p<0.02 100% N2 vs 30 min 
p<0.03 100% o2 vs 30 min 
** p<0.02 100% N2 vs 100% 02 
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cotransport and the Cl-/HC0 3-exchange (Vaughan-Jones, 1988; 
Poole-Wilson, 1989). The average pH's of the effluents from 
the 100% o 2 group at 8.4 ± 0.1 were higher than with 100% N2 
at 8.1 + 0.06, which corresponds to the difference between the 
pH of the arterial cardioplegic solutions (Table 6). During 
arrest, mean pH's were significantly different over the last 
three flushes (p<0.02). This may also have been an indication 
of reduced proton production by glycolysis, and increased 
proton consumption by oxidative phosphorylation with a high 
po2 in the cardioplegic solution. 
d) LOH washout 
Mean LOH content of the effluents showed greater washout with 
100% o 2 during arrest compared to 100% N2 . These differences 
were significant at all times between the two groups (p<0.04) 
(except for the last flush because of a large variance) 
(Figure 6). There was a significant decrease in washout over 
time in the 100% .- N 2 group ( p<O. 04), but not with 100% o 2 . 
Average washout was almost double with oxygenation, with 67.4 
± 4.7 mU/gm/6ml versus 34.0 ± 2.5 mU/gm/6ml (p<0.001) (Table 
8) • 
Post-ischaemic washout of LOH was not significantly different 
between the two groups, al though slightly higher with 
intermittent reoxygenation (Table 8). 
e) Lactate washout 
Average lactate 
high, at 3. 7 ± 
02 ( 2. 0 ± 0. 1 
washout during arrest with 100% N 2 was 
O. 3 µmol/gm/6ml almost double that with 




lactate production with the 100%N 2 group is a result of the 
Pasteur effect in which glycolysis is stimulated in the 
absence of oxygen (Opie, 1989c). Significant differences in 
mean washout for each flush were only seen at 90 min, possibly 
because of a high variance in lactate measurements (Figure 7). 
There was not a significant variation in lactate washout with 
time in either group, possibly due to an accumulation of 
lactate in the tissue without efficient washout (Figure 7). 
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30 60 90 120 150 
Time (min) 
[ill 100% N2 
~ 100% 02 
Fig. 6. Means± sem of washout of lactate dehydrogenase (LDH) 
during arrest per 6ml flush of cardioplegic solution. 
Comparison of hearts arrested with St Thomas' Hospital 
cardioplegic solution No. 2 with 11 mmol/1 glucose gassed with 
100% N2 (n=6), or 100% o2 (n=S). Arrested hearts were 
intermittently flushed with cardioplegic solution over 3 hours 
at 10°c. 
* p<0.04 100% N2 vs 100% o2 
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Time (min) 
O] 100% N2 
~ 100% 02 
Fig. 7. Means ± sem of washout of lactate during arrest per 
6ml flush of cardioplegic solution. Comparison of hearts 
arrested with St Thomas' Hospital cardioplegic solution No. 2 
with 11 mmol/1 glucose gassed with 100% N2 (n=6), or 100% o2 
(n=S). Arrested hearts were intermittently flushed with 
cardioplegic solution over 3 hours at 10°c. 
* p<0.03 100% N2 vs 100% 02 
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f) Tissue high energy phosphates after reperfusion 
The tissue ATP measurements for both groups were significantly 
less than control values ( p<O. 03) while no differences were 
seen between the two groups ( Table 9) . CP levels were no 
different compared to control levels or between groups (Table 
9). There was no definite indication of improved conservation 
of energy with 100% o2 , although this must be looked at in the 
context of functional recovery. 
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Table 9: Means ± sem of tissue levels of adenosine 
triphosphate (ATP) and creatine phosphate (CP) of control 
hearts clamped after 10 minutes work before arrest, and of 
arrested hearts after 20 minutes reperfusion. Comparison of 
hearts arrested with St Thomas' Hospital cardioplegic solution 
No. 2 with llmmol/1 glucose gassed with 100% N2 , 100% o2 , 
95%N2 5%C02 or 95%02 5%co2 . Arrested hearts were 




Control 3.91 ± 0.25 5.05 ± 0.46 
(n=6) 
100% N2 2.08 ± 0.37 * 4.39 ± 0.62 
(n=6) 
100% 02 2.48 + 0.12 * 4.05 + 0.29 
(n=8) 
95%N 2 5%C0 2 2.57 ± 0.13 * 4.67 ± 0.44 
(n=7) 
95%02 5%C0 2 2.66 + 0.38 * 3.46 ± 0.70 
(n=9) 
* p<0.03 vs control 
ii) Multidose arrest with ST+Glucose gassed with 95%N2 5%co2 
or 95%02 5%C02 
a) pH and p02 of the cardioplegic solutions 
To test the hypothesis of a beneficial effect of oxygenation 
at a decreased pH in a glucose-containing solution, the 
ST+Glucose solution was gassed with 95%N 2 5%C0 2 or 95%0 2 
5%co2 . 95%02 5%C02 was chosen as this is the gas composition 
used to aerate the K-H buffer during perfusion of an isolated 
heart. The presence of co2 reduces the pH to about 7. O for 
both anoxic and highly oxygenated solutions (Table 6), 
al though the pH for the oxygenated solutions were slightly 
higher. This may be due to the differences in the solubility 
coefficients for oxygen and nitrogen, which is reflected in a 
slightly higher pco 2 in the 95%N 2 5%C0 2 group. The reduction 
in the amount of nitrogen dissolved in solution enables a 
greater amount of co2 to be present. 
b) Functional recoveries 
Pre-ischaemic control values for functional measurements were 
not significantly different (Table 7). 
Gassing the ST+Glucose solution with 95%0 2 5%C0 2 resulted in 
overall recoveries of about 90%. These were significantly 
greater than recoveries with 95%N2 5%co2 (p<0.05). The 
inclusion of oxygen in an acidotic solution was beneficial. 
c) pH of coronary effluents 
When the arrested hearts were flushed with ST+Glucose gassed 
with 95%N2 5%co2 or 95%02 5%C02 , the mean effluent pH's showed 
gradual decreases with time to about 7.1 (Figure 8). Average 
pH's for the effluents were very similar between the two 
groups, with 7.1 ± 0.01 for 95%N2 5%C02 , and 7.2 ± 0.02 for 
95%02 5%co2 , although initially pH for 95%02 5%co2 was 
significantly higher than for 95%N2 5%co2 (7.3 ± 0.05 vs 










0 30 60 90 120 150 
Time (min) 
Fig. 8. Means± sem of pH's of the coronary effluent samples 
during arrest. Comparison of hearts arrested with St Thomas' 
Hospital cardioplegic solution No. 2 with 11 mmol/1 glucose 
gassed with 95%N2 5%co2 (pH 6.98 ± 0.01, n=7), or 95%02 5%C02 
( pH 7. 07 ! O. 02, n=8). Arrested hearts were intermittently 
flushed with cardioplegic solution over 3 hours at 10°c. 
* p<0.05 95%0 2 5%co 2 vs 30 min 
** p<0.05 95%N 2 5%C0 2 vs 95%02 5%C02 
All values were significantly different between low pH and 




oxygenated group may be due to consumption of protons by 
increased oxidative phosphorylation. 
d) LDH washout. 
Mean LOH washout during arrest showed a significant decline 
over time in hearts flushed with ST+Glucose gassed with 95%02 
5%co2 (p<0.04) (Figure 9). A similar trend was observed in the 
95%N 2 5%C0 2 group, although this was not significant (Figure 
9). Average LOH washout during arrest was significantly lower 
in the presence of oxygen with 37. 7 ± 2. 6 mU/gm/6ml versus 
56.3 ± 4.9 mU/gm/6ml for the anoxic group (p<0.001) (Table 8). 
The presence of oxygen thus reduced membrane damage associated 
with a low pH. 
Post ischaemic loss of LOH was also greater with the anox1c 
acidic group, at 125. 4 ± 12. 3 mU/gm/min, compared to 60. 7 ± 
6.7 mU/gm/min with the 95%0 2 5%co 2 group (p<0.002) (Table 8). 
e) Lactate washout. 
Average lactate washout during arrest was slightly lower with 
95%02 5%co2 than with 95%N2 5%C02 (Table 8). There was a 
significant decline in lactate washout with time in the 95%02 
5%co2 group ( p<O. 04) , al though with 95%N 2 5%co2 there was a 
significant increase with time (p<0.04) (Figure 10). On 
reperfusion, lactate washout was marginally greater in the 
95%02 5%co2 group. 
f) High energy phosphate levels 
The tissue ATP after reperfusion showed a slight increase in 
the 95%0 2 5%co 2 group as against 95%N 2 5%C0 2 although this was 
not significant (Table 9). These were both significantly less 
than control values for ATP (p<0.03). CP levels did not differ 
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Fig. 9. Means± sem of washout of lactate dehydrogenase (LDH) 
during arrest per 6ml flush of cardioplegic solution. 
Comparison of hearts arrested with St Thomas' Hospital 
cardioplegic solution No. 2 with 11 mmol/1 glucose gassed with 
95%N 2 5%co 2 ( n=7), or 95%0 2 5%co 2 ( n=8 )Arrested hearts were 
intermittently flushed with cardioplegic solution over 3 hours 
at 10C?c. 
** p<0.04 95%02 5%co2 vs 30 min 
* p<0.02 95%N 2 5%C0 2 vs 95%02 5%Co 2 
* p<0.03 95%N 2 5%Co 2 vs 100% N2 
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Fig. 10. Means± sem of washout of lactate during arrest per 
6ml flush of cardioplegic solution. Comparison of hearts 
arrested with St Thomas' Hospital cardioplegic solution No. 2 
with 11 mrnol/1 glucose gassed with 95%N2 5%co2 (n=7), or 95%02 
5%co2 (n=8). Arrested hearts were intermittently flushed with 
cardioplegic solution over 3 hours at 10°c. 
** p<0.04 95%02 5%C0 2 vs 60, 90 min 
** p<0.03 95%N 2 5%C0 2 VS 30 min 
* p<0.001 95%N 2 5%C0 2 VS 95%02 5%Co2 
* p<0.04 95%N 2 5%C0 2 vs 100% N2 
* p<0.03 95%02 5%co 2 VS 100% 02 
iii) Comparison of oxygenation with and without 5%co2 
a) Functional recoveries 
The presence of 5%Co 2 in the cardioplegic solution with both 
anoxic and oxygenated hearts improved functional recovery 
(Table 7). The improvement seen with anoxic hearts was about 
10-15% in aortic output (p<0.05). There was also a significant 
improvement in recovery between the two oxygenated groups with 
a decrease in pH. Optimal recoveries were attained when 
gassing the ST+Glucose solution with 95%02 5%co2 . 
b) LDH efflux during and after arrest 
There was a significant difference in the mean washout of LDH 
during arrest between the two nitrogen groups especially at 
the later flushes (p<0.03) (Figures 6 and 9). This was 
reflected in the average efflux, with 56.3 ± 4.9 mU/gm/6ml at 
the lower pH, compared to the anoxic alkaline solution, with 
34.0 ± 2.5 mU/gm/6ml (p<0.001) (Table 8). Post-ischaemic LOH 
efflux was also significantly greater with the inclusion of 
co 2 , at a level about three times higher (p<0.001) (Table 8). 
A harmful effect of a lower pH on membrane integrity was 
observed. 
Oxygenation with a high pH was also associated with increased 
membrane damage. However, with oxygenation at a low pH, LOH 
release was significantly reduced, both versus 100% o 2 
(p<0.05) and 95%N2 5%co2 (p<0.002) (Table 8). A low pH will 
inhibit ca 2+ entry and free radical activity, while 
stimulation of oxidative phosphorylation may further protect 
the heart by increasing energy levels during ischaemia. 
c) Lactate washout during and after arrest 
The average lactate washout during arrest of the 95%N 2 group 
and both o 2 groups were significantly lower than that of the 
100% N 2 group, by about half (p<0.05) (Figures 7 and 10). 
Washout in these three groups was similar. Post-ischaemic 
lactates did not show any significant differences between the 
groups (Table 8). There was a tendency for slightly greater 
washout on reperfusion with the lower pH's, possibly linked to 
extrusion of lactate together with protons on reperfusion with 
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a relatively alkalotic solution (K-H pH 7.4). Preservation of 
glycolytic pathways with a low extracellular pH is possibly 
indicated. 
d) Oxygen uptake 
The po 2 of the cardioplegic solutions was similar (Table 6) 
although the mean oxygen uptake by the hearts per 6 ml flush 
was greater in the presence of co2 (Figure 11) where average 
uptake with 100% o 2 was 0.0758 ± 0.002 ml o 2/gm/6ml and with 
95%02 5%C02 was 0.0835 ± 0.003 ml o 2/gm/6ml (p<0.05). (The o2 
uptake of the nitrogen groups could not be determined because 
of the low po 2 of the effluent which therefore picked up 
oxygen from the atmosphere very rapidly). There was thus 
greater oxidative phosphorylation at the lower pH, with 
enhanced energy production. A significant decline in oxygen 
uptake over time was seen in both groups, until equivalent 

































Fig. 11. Means ± sem of oxygen uptake during arrest per 6ml 
flush of cardioplegic solution. Comparison of hearts arrested 
with St Thomas' Hospital cardioplegic solution No. 2 with 11 
mmol/1 glucose gassed with 100% o 2 (0.184 ml o 2/6ml, n=6), or 
95%02 5%co2 (0.187 ml o 2/6ml, n=7). Arrested hearts were 
intermittently flushed with cardioplegic solution over 3 hours 
at 10°c. 
* p<0.04 100% 02 VS 30 min 
** p<0.03 100% 02 vs 60 min 
* p<0.04 95%02 5%C0 2 VS 30 min 
** p<0.04 95%02 5%Co 2 vs 60 min 
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iv) Properties of the ST+Glucose cardioplegic solution 
a) Temperature, pH and oxygenation 
The ST+Glucose solution was either open to atmosphere, or 
gassed with 100% o 2 or 95%0 2 5%co 2 . Similar slopes for the 
non-gassed and 100% o 2 solutions were obtained, although the 
pH's were different (Figure 12). However, in the presence of 
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Fig. 12. Change in pH with temperature of the St Thomas' 
Hospital cardioplegic solution No. 2 open to atmosphere 
(aerated), or gassed with 100% o 2 or 95%0 2 5%co 2 . Also shown 
are curves for pure water and ectotherm tissue. 












b) Titration curves and buffering capacities 
The titration curves for the ST+Glucose solution open to 
atmosphere, or gassed with 100% o 2 or 95%02 5%co2 , were 
determined at 10°c ( Figure 13). There was a shift in the 
curves dependent on the co2 concentration. The pK' s for the 
solutions were about 6.35 to 6.40 at 10°c. 
The buffering capacities for ST+Glucose determined from the 
titration curves (Figure 14) show that the range of buffering 
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13. Titration curves of the St Thomas' Hospital 
cardioplegic solution No. 2 gassed on preparation with 95%02 
5%co2 and open to atmosphere (aerated), or continually gassed 
with 100% o 2 or 95%02 5%co2 . The solutions were kept at 10°c. 
The inflection points of the curves give the pK for the 
solution, at 6.4. Increases 1n the co2 content lead to a 
downward shift in the curve. 
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Fig. 14. Buffering capacity of the St Thomas' Hospital 
cardioplegic solution No. 2 gassed on preparation with 95%02 
5%co2 and thereafter left open to atmosphere (aerated), or 
continually gassed with 100% o 2 or 95%0 2 5%co 2 . The solutions 
were kept at 10°c. Buffering capacity is expressed as the 





i) Oxygenation of the ST+Glucose solution 
The addition of oxygen to the ST+Glucose cardioplegic solution 
used in a multi dose protocol increased functional recovery 
compared to anoxic solutions. This may be related to enhanced 
energy production by oxidative phosphorylation during arrest 
and improved mitochondrial function on reperfusion. 
The premise that an increase in glycolytic rate is of benefit 
to the arrested heart seems to be countered by the results of 
this experiment, as increased lactate output in the 100% N 2 
group did not lead to improved recovery of the hearts. 
Intracellular accumulation of lactate has been shown to have 
deleterious effects on the cells (Neely and Grotyohann, 1984; 
Hagberg, 1985; Opie, 1990). The high rates of glycolysis as 
shown by the high lactate washout with the 100% N2 group may 
also contribute to developing acidosis, 
greater washout of protons compared to 
which is shown by a 
the 100% o2 group. 
However, the washout of lactate does not necessarily reflect 
the rate of glycolysis, as there may have been an accumulation 
of lactate in the cells. The instantaneous rates of glycolysis 
may have shown different trends. Lactate may have also been 
consumed by oxidative phosphorylation with 100% o2 present, 
and the two groups may in fact have shown similar rates of 
glycolysis. 
An accumulation of protons in the cells 
deleterious effects. However, with a 
is associated with 
high arterial pH 
intermittently reintroduced, the protons may be extruded down 
the restored concentration gradient, possibly in exchange for 
Na+ with removal of inhibition of the Na+;H+ exchanger. This 
may allow the entry of ca2+ by the Na+;ca2+ exchange. 
In the presence of oxygen, an increased lactate may be 
beneficial as it can be used as an independent source of 
energy by the Krebs cycle, thus reducing lactate efflux. 
However, when gassing the cardioplegic solution with 100% o2 , 
glycolysis may also be inhibited by this metabolite, although 
the stimuli of cessation of coronary flow and a high pH are 
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fairly strong. Relative inhibition of glycolysis will reduce 
lactate and intracellular proton build up, while increased 
oxidative phosphorylation will consume protons and lactate. 
The pH of the coronary effluents reflects this, as the pH's 
for the 100% o 2 group were higher than with 100% N2 . However, 
the arterial pH of the latter solution tended to be lower than 
with the former. This may be due to the different solubility 
coefficients of nitrogen (16.9 ml 0 2;1 solution at 15°c) and 
oxygen (37 ml 0 2/1) resulting in slightly greater pco2 's with 
the former, al though the measured pco2 's for the solutions 
were similar. This may have led to a slight bias in the 
effluent pH's but the overall trend is still significant. 
With oxygenation, substrates are utilised in a more efficient 
way by oxidative phosphorylation than by glycolysis, with more 
ATP produced per mole glucose. In addition, the Krebs cycle 
utilises pyruvate thereby limiting the production of lactate 
and protons (Opie,_ 1989c). In the presence of glucose, energy 
production in the arrested heart may then be optimal since 
both glycolysis and oxidative phosphorylation are active 
without excessive build up of lactate and protons. 
The beneficial effect of oxygenation of cardioplegic solutions 
is well documented (Bodenhamer et al., 1983; Guyton et al., 
1985; Coetzee et al., 1986; Boggs et al., 1987; Hendren et 
al., 1987; de Wit et al., 1988; Ledingham et al., 1988), and 
supported by the results of these experiments. However, other 
studies have used different protocols and different solutions 
to test the effect of oxygenation. 
Bodenhamer et al. (1983) used a hypothermic (4°C) potassium 
crystalloid cardioplegic solution (mmol/1 Na+ 118, K+ 27, pH 
7. 4) over a 4 hour arrest period with reinfusions every 20 
min. Oxygenation with 100% o 2 as opposed to simple aeration 
( open to atmosphere) of the cardioplegic solution was 
beneficial. Preservation of high energy phosphate stores was 
greatly improved in the presence of a high po2 . Guyton et al. 
(1985) also found a beneficial effect with an oxygenated (100% 
o 2 ) crystalloid cardioplegic solution (mmol/1 - Na+ 160, K+ 
30, ca 2+ O) infused intermittently. 
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Boggs et al. ( 1987) used the isolated rat heart and found a 
salutary effect of oxygenation with 98%02 2%C02 (pH± 7.4) in 
a hyperkalaemic cardioplegic solution (mmol/1 - Na+ 110, K+ 
20, Mg2+ o, glucose 28) (mul tidose protocol at 4°C over 2 
hrs). 
The beneficial effects of both ST No 1 and No 2 solutions are 
increased when oxygenated with 100% o 2 , at a temperature of 
20°c (po 2 320-560 mmHg, pH 8.2) as against aeration (po 2 
greater than 150 mmHg, pH 7.9) (Ledingham et al., 1988). This 
study was conducted with mul tidose cardioplegia at a 
temperature of 20°c in the isolated working rat heart. 
However, when comparing the recoveries attained with 100% o 2 
in this study, versus those observed in the initial studies 
with aerated ST+Glucose ( see above), a reduction in function 
with the former solution was seen. The discrepancy between 
these results and those of Ledingham et al. (1988) may be due 
to the differences in pH of the solutions [pH 7.4-7.8 
ST+Glucose (aerated) versus pH 9.3 with 100% o 2 ; and pH 7.9 ST 
(aerated) versus pH 8.2 (100% o 2 )(Ledingham et al., 1988)]. A 
much larger change in the pH between the different solutions 
was observed in the present series of experiments, possibly 
due to the differences in temperature of the solutions (10°c 
versus 20°c) . The intermittent reintroduction of the highly 
alkaline solution with a high po2 may have led to the 
formation of oxygen free radicals, exacerbating the membrane 
damage linked to ischaemia and multi dose cardioplegia, and 
increasing reperfusion injury. These effects may reduce the 
functional recovery despite an improved energy production. An 
additional variable therefore to be taken into account with 
oxygenation of the solution was the change in pH observed. A 
comparison of a high and a low pH for cardioplegic solutions 
was then made, either without or with oxygenation. 
ii) pH of the ST+Glucose solutions 
a) Acidotic solutions 
The use of an acidotic anoxic solution resulted in an 
improvement in functional recovery as opposed to an anoxic 
91 
solution with a high pH. There was a decrease in lactate 
production, due to inhibition of glycolysis by a low pH. 
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However, with the acidotic anox1c solution, there was an 
increase in LOH washout during and after arrest, indicating a 
harmful effect of a low pH on cell membranes. This was negated 
by the improved functional recovery. There was also an 
increasing washout of lactate in the 95%N2 5%Co2 group. This 
is conflicting as there was a decrease in the effluent pH over 
time, although a low pH is associated with inhibition of 
glycolysis. However, the stimulus of no flow and a lack of 
oxygen on glycolysis appears to be greater than the inhibitory 
effect of the low pH over time. The presence of glucose may 
also have stimulated glycolysis under these conditions. An 
accumulation of lactate in the myocardium was possibly found 
in this group. 
Perfused hypothermic hearts function more efficiently with an 
alkaline solution. A rapid decline in contractility is 
observed in the perfused rat heart in response to increased 
co2 ( Poole-Wilson and Langer, 1975) with a reduction in pH 
from 7.4 to 6.8. However, arrested hearts have been shown to 
respond better to acidotic cardioplegic solutions (Nugent et 
al., 1982; Bernard et al., 1985). This was substantiated by 
the above experimental results. The use of a hyperkalaemic 
cardioplegic solution (K+ 25 mmol/1) titrated with bicarbonate 
(Nugent et al., 1982) indicated that an alkaline solution (pH 
7.70) had a significantly depressive effect on postarrest left 
ventricular function, compared to an acidotic solution (pH 
7 .10). A decreased o 2 consumption was observed with pH 7 .1, 
indicating greater conservation of energy. A study by Bernard 
et al. ( 1985), using the NMR technique to determine 
intracellular pH in perfused hearts, substantiates the 
hypothesis of an increase in recovery with a relatively 
acidotic, ca 2+-containing cardioplegic solution. 
The mechanisms for energy production on reperfusion of the 
heart may be better preserved with an acidotic solution, which 
will enhance the ability of the tissue to recover. The stores 
of ATP may also be increased because of inhibition of 
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contractile activity during arrest, with interaction of 
factors including hypothermia, the increased K+ concentration 
and inhibition of activation of contraction by the low pH. 
Measurement of ATP levels at the end of ischaemia would help 
to elucidate this point. 
b) Use of alkaline cardioplegic solutions 
In contradiction to the above findings, several researchers 
recommend the use of alkalotic cardioplegic solutions. 
Recordings of intramyocardial pH of human hearts during arrest 
when intermittently flushed with an acalcaemic cardioplegic 
solution (pH 7.8) at 4°c, indicate that maintenance of mean pH 
during the aortic cross clamp period is well correlated with 
recovery (Khuri et al., 1983). A myocardial pH of 7. 4 was 
associated with maximum recoveries, while pH's of 6. 7 gave 
minimum recoveries. Prevention of acidosis during a 
cardioplegic arrest period was thought to be beneficial. 
Takach et al. ( 1986) also measured intramyocardial pH during 
cardioplegic arrest. A pH of 6.8 was used as an end point, at 
which recovery of all the hearts was found to correlate at a 
low level. The time taken to reach this point was used as an 
index of efficacy of the solutions. Hypothermia was deemed to 
be advantageous by slowing the decline in pH. The convention 
thus established was that a low pH allowed to develop in the 
arrested heart is detrimental to its recovery. The use of an 
alkalotic solution was therefore advocated. 
Another argument for the use of an alkalotic cardioplegic 
solution is the relationship of temperature and pH. A drop in 
the temperature of a solution is associated with an increase 
in pH (White, 1981), as there is greater binding of protons 
with anions. Ectotherms maintain the pH of their body fluids 
parallel to the neutral point of water by decreasing the pco 2 
with changes in temperature (Reeves and Malan, 1976). This 
strategy preserves the charge state of proteins, maintaining 
enzyme activity (Reeves and Malan, 1976). In extrapolation to 
cardioplegic solutions, ·Swan ( 1984) and others recommend a pH 
of 7. 8, in a fully oxygenated solution used at 4-8°c. This 
strategy has been commonly applied by cardiac surgeons. 
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However, hibernating animals maintain a relatively low 
arterial pH of about 7.4 with decreasing temperatures (White, 
1981). This is linked to preservation of energy stores. 
Metabolic activity is decreased both by the drop in body 
temperature to about 5°c, and proton inactivation of the 
enzymes with subsequent conservation of energy. 
Becker et al. (1981) looked at the relationship between pH, 
pco2 and temperature of cardioplegic solutions in higher 
mammals (puppies) . The pH of the cardioplegic solution was 
maintained either at 7.4 (physiological pH at 37°C) by 
maintaining a constant pco2 of 40 mmHg; or respiratory 
alkalosis was induced by decreasing the pco 2 to 10 ± 4 mmHg at 
11°c, to bring about pH values as would be found 1n the 
ectotherm. The pH was thereby increased to 7.85. The results 
showed better recovery of cardiac output with the pH-adjusted 
group, with a decreased lactic acidosis and prevention of 
ventricular fibrillation. This study used blood cardioplegia, 
and mul tidose administrations, with total body cooling. This 
should not be extrapolated to crystalloid solutions, because 
of the effect of oxygen and different buffering capacities of 
blood. 
In our studies, a comparatively low extracellular pH and 
presumably a decreased intracellular pH led to better recovery 
of the hearts. The drop in pH associated by others with 
decreased recovery may be due to lower calcium concentrations 
used, or the absence of o 2 . There may also be a critical limit 
on acidosis. The presence of glucose may also affect the 
results obtained with an increase in the glycolytic rate 
affecting intracellular proton levels. 
c) Limit of extracellular acidosis 
While a mild acidosis appears to be beneficial, in our 
experiments the effluent pH's did not drop below 7. 00, which 
may be above a certain critical limit (Bernard et al, 1985). A 
severe acidosis of less than 6.6 leads to cellular necrosis, 
with activation of lipases and proteases, whereas decreasing 
extracellular pH only to 7.00 may be advantageous. This 
approximates the intracellular pH of a normal myocardial cell 
(Roos and Boron, 1981). The effect of pH on phospholipase 
activation may be counteracted by the beneficial effect of 
acidosis on ca 2+ entry and activity. This may account for the 
high efflux of LOH during and after arrest with the use of the 
acidotic solution (95%N 2 5%C0 2 ), but an increased recovery of 
the myocardium despite this. 
The optimal pH of a cardioplegic solution may depend on the 
temperatures involved as well as the solution used. The 
species tested may also be a determining factor. 
d) ca2+ entry on reperfusion 
Acidosis is thought to be protective because of inhibition of 
Ca 2+ binding, and preservation of energy stores ( see 
Introduction). This is of advantage 1n cardioplegia, where a 
reduced ca 2+ influx and decreased ATP consumption is desired. 
Moderate acidosis also appears to be beneficial 
reperfusion of the heart after ischaemia, as well as 
hypoxia (Kitakaze· et al., 1988), as this prevents 
upon 
after 
ca 2 + 
overload on reperfusion, one of the major putative causes of 
damage associated with an ischaemic period. 
A possible mechanism for the prevention of ca2+ overload on 
reperfusion involves the Na+;H+ and the Na+;ca2+ exchangers. 
The activity of the Na+ /H+ exchanger is dependent on the 
proton gradient. 
is almost nil at 
al., 1985; Kaila 
Its activity is enhanced at acidic pH's 
normal and alkalotic pHi 's. ( Lazdunski 
and Vaughan-Jones, 1987). When the pHi 
lower than 
extracellular 
pH0 , protons cross 
space, leading to 







accumulation. During ischaemia, intracellular acidosis 
develops. There is thus a proton gradient, leading to 
extrusion of protons via the Na+;H+ exchange. However, 
extracellular pH is then reduced with a lack of coronary flow, 
which causes inhibition of the exchanger ( Lazdunski et al. , 
1985). With inhibition of the Na+/H+ exchange in sheep 
Purkinje fibres, there is a decrease in Na+ accumulation in 
the cell, and therefore prevention of ca2+ influx via the 
Na+;ca 2+ exchange (Vaughan-Jones et al., 1989). Thus, in the 
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presence of a low extracellular Na+ or low pH 0 , contractility 
is decreased. 
On reperfusion, however, with the reintroduction of a 
relatively alkalotic solution (usually pH 7. 4), the gradient 
is increased causing efflux of protons in exchange for Na+. 
This alteration in the Na+ gradient in turn activates the 
Na+;ca 2+ exchange with the subsequent influx of ca 2+. 
With the use of an alkalotic cardioplegic solution introduced 
at intermittent intervals, the Na+;H+ exchanger may be 
intermittently reactivated, leading to the accumulation of Na+ 
and ca 2+ in the cell. With the use of an acidotic cardioplegic 
solution, however, the Na+;H+ exchanger will be inhibited 
because of a reduced proton gradient. Thus an acidotic 
cardioplegic solution is proposed to be beneficial by 
inhibition of ca 2+ entry, as well as suppression of ca2+ 
activity in the cytosol with a high proton concentration. 
In contradiction · to the above hypothesis, reperfusion after 
arrest with the acidotic anoxic solution resulted in a large 
washout of LDH. While this does not seem to be reflected in 
the recovery of the hearts, the cell membranes may be 
vulnerable 
with ca 2+ 
to reperfusion with the alkalotic K-H solution, 
entry no longer inhibited. The amount of ca 2+ 
entering on reperfusion will, however, be reduced if the 
membranes are not damaged during the arrest period. 
The use of an acalcaemic solution is associated with the ca2+ 
paradox on reinfusion of a ca2+ containing perfusate (Ruigrok 
et al., 1983). This effect is inhibited by a low pH. Even 
though sufficient ca 2+ is present in the ST solution to 
prevent the appearance of this phenomenon (more than 50 
µmol/1), the benefit of an acidotic solution is still 
apparent. 
iii) pH, oxygenation and glycolysis 
a) Beneficial effects of ST+Glucose gassed with 95%02 5%co2 
The use of a low pH in a highly oxygenated solution proved to 
be the best combination, with high functional recoveries. 
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Hendren et al. (1987) also determined the effect of 
oxygenation and alterations in %CO 2 of an acalcaemic 
bicarbonate-containing cardioplegic solution using the 
Langendorf f isolated rat heart model. However, this solution 
was acalcaemic. The solution was used at a temperature of s0 c 
with mul tidose infusions. The calcium paradox was found upon 
reperfusion with the 100% o 2 solution where the inclusion of 
o 2 at a high partial pressure drives the pH upward by blowing 
off the co 2 . A decreased pH with the acalcaemic solution was 
found to increase recovery of the hearts, with maximal 
recovery with a pH of 7.11 (5% co2 ). Using the calcium 
containing ST+Glucose solution, a similar value for pH was 
found to be optimal. 
LOH washout was reduced as was lactate production and 
presumably intracellular proton accumulation, although this 
was not reflected in the effluent pH's. With oxygen present, 
lactate can be used as a substrate, while glycolysis is also 
inhibited, both by the presence of oxygen, and an 
intracellular accumulation of protons (Ravetto et al., 1975). 
This will reduce washout of lactate. However, buffering and 
membrane transport of protons also contribute to reducing 
changes in pH. Intermittent washout may reduce a build up of 
protons, and slow the development of intracellular acidosis. 
Post-ischaemic lactate was relatively high, indicating a fair 
rate of glycolytic ATP production on reperfusion, although 
during arrest, gassing with 95%0 2 5%co 2 was lowest of all 
groups. There was also increased uptake of oxygen with a lower 
pH, in the presence of a high po2 . Thus al though levels of 
high energy phosphates 20 min after reperfusion did not show 
differences between groups corresponding to recovery, the 
indications are that increased availability of energy 
substrate during arrest is good, and results in better energy 
production on reperfusion. 
The benefits of maintaining ATP production during ischaemia, 
and preserving the mechanisms for the production of ATP upon 
reperfusion, may act together tQ increase the beneficial 
effect observed with 95%02 5%C02 in the presence of glucose 
with intermittent flushing. While the inclusion of glucose in 
the ST solution may affect myocardial pH by increasing the 
glycolytic rate, thereby increasing the gradient for the 
efflux of protons, and subsequent intracellular ca 2+ 
accumulation, this is inhibited by the use of a cardioplegic 
solution with a low pH. With oxygen present, the rate of 
glycolysis will be reduced with a decline in the rate of 
acidosis, while energy production is 





metabolic waste products is also beneficial to the arrested 
hearts. Oxygenation and multidose delivery, together with 
hypothermia, are thought also to protect the heart against the 
calcium paradox. 
While the recoveries attained with 95%0 2 5%C0 2 were better 
than those of the other groups in this series of experiments, 
when compared with the initial studies using the ST+Glucose 
solution intermittently (Table 3), no significant difference 
in recovery was seen between the two groups. Recoveries in 
both groups were in the region of 88-90%. However, in tjle 
initial studies it must be emphasised that the solutions were 
gassed and did contain oxygen and carbon dioxide. However, the 
exact value of these variables was not determined. A direct 
comparison of these two series of results cannot therefore be 
made. 
b) Oxygen uptake 
The oxygen tension gradient is the main determinant of the 
amount of o2 which can be taken up, as shown by comparison 
between an aerated and an oxygenated solution ( Bodenhamer et 
al., 1983). The dissociation curve of a crystalloid solution 
is linear and all o2 in such a solution can be released 
(Digerness et al., 1981). 
A comparison of oxygenated blood and crystalloid cardioplegia 
by Digerness et al. (1981) indicates that the amount of oxygen 
available at 10°c and 20°c is much the same for the two 
solutions. Blood had an oxygen availability of 3.61 ml 
0 2;100 ml and 5.08 ml 0 2;100 ml respectively for the two 
temperatures, while the crystalloid cardioplegia cited had 
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oxygen contents of 4.06 ml 0 2/100 ml and 4.00 ml 0 2;100 ml 
respectively. In comparison, the ST+Glucose solution contained 
3.07 ml 0 2;100 ml (100% o 2 ), and 3.12 ml 0 2/100 ml (95%0 2 
5%co2 ) at 10°c. 
In the arrested dog heart, oxygen consumption has been 
measured at a basal rate of 0.3 ml/100 gm/min at 22°c 
(Buckberg et al., 1977), 0.27 ml/100 gm/min at 15°c and 
o .13 ml/100 gm/min at 5°c ( Bretschneider et al. , 1975). By 
regression of this curve, the oxygen consumption at 10°c is 
about O. 19 ml 0 2;100 gm/min, or 1. 9 µl o 2/gm/min. The 
metabolic rates of dog and man can be more closely compared 
than rat and man, and presumably a similar oxygen uptake in 
the arrested heart exists for the two species. The consumption 
of the rat heart has been assumed to be twice that of dogs 
(Ledingham et al., 1988). 
Our results indicate that the uptake of oxygen at 10°c from 
the oxygenated ST~Glucose solution at a pH of 7 is about 40% 
greater in the rat heart than that in the dog heart. The 
oxygen consumption of the arrested rat hearts was about 
2.52 µl o 2/gm/min (100% o 2 ) and 2.78 µl o 2/gm/min (95%02 
5%C0 2 ) at 10°c (amount taken up from the cardioplegic solution 
- however, there may also be diffusion from the atmosphere). 
Oxygen uptake was about 40-45% of that supplied by the 
cardioplegic solution. Sufficient provision of oxygen in the 
gassed crystalloid cardioplegic solution therefore exists to 
satisfy the needs of the arrested human heart. Uptake of o2 is 
enhanced at the lower pH and this may be sufficient to prevent 
the so-called "oxygen debt", especially with the lowered 
metabolic rate at hypothermia. 
The use of an oxygenated crystalloid cardioplegic solution at 
low temperatures may be more beneficial than blood because of 
the effect of temperature on the o2-haemoglobin dissociation 
curve, where a left shift occurs (Kanter et al., 1981). 
Release of oxygen from haemoglobin is reduced as the 
temperature is decreased and the oxygen taken up by the cells 
must be from that dissolved in solution. 
Oxygenation of a crystalloid cardioplegic solution, as opposed 
to the use of oxygenated blood cardioplegia, is a safe and 
effective way of delivering oxygen, the supply of which is of 
benefit to the heart. 
The greater o2 uptake by the 95%0 2 5%C0 2 group is indicative 
of a higher metabolic rate resulting in increased ATP 
production by oxidative phosphorylation. The glucose provided 
in the solution is therefore efficiently metabolised, without 
excess accumulation of harmful metabolites. The addition of 
this ATP together with glycolytically derived ATP appears to 
be beneficial to the arrested hearts. 
There was a decline in oxygen uptake over time in the 
oxygenated groups, which may decrease further if the time of 
arrest is extended. This may have a crucial role in 
determining the recovery of the hearts. With a decreased 
oxygen uptake, glycolysis may then increase, with the harmful 
effects associated with increased intracellular proton 
concentration. The pH gradient will be increased, leading to 
intracellular ca 2+ accumulation. 
c) Free radicals scavengers in a cardioplegic solution 
Gassing the ST+Glucose cardioplegic solution with 100% o2 , 
while resulting in improved recoveries compared to the 
alkaline anoxic solution, indicated a negative effect with a 
high LOH washout during arrest, with reduced recoveries when 
compared to the aerated ST+Glucose solution (see above). This 
effect may have been due to the formation of oxygen free 
radicals whenever the oxygen was reintroduced with 
intermittent flushing, as the preceding ischaemic period is 
thought to predispose the tissue to the formation of these 
molecules. This phenomenon may be combated in several ways, 
including the use of free radicals scavengers in the 
cardioplegic solution. Enzymatic free radical scavengers have 
been added to cardioplegic solutions in order to prevent the 
accumulation of these molecules during and after arrest 
(Halliwell, 1989; Jurmann et al., 1988; Gharagozloo et al., 
1988; Chambers et al., 1989). 
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Glucose is also thought to have a direct free radical 
scavenging activity (Hearse and Humphrey, 1975). Its presence 
during hypoxia significantly reduces free radical activity on 
the reintroduction of oxygen (Hess et al., 1983). This may 
also be due to an increased rate of anaerobic glycolysis, with 
consumption of the precursors of ATP, thereby inhibiting the 
predisposition of the myocardium to the formation of free 
radicals. This indicates the importance of maintaining 
substrate levels and preventing the susceptibility of the 
heart to the initiation of the oxygen paradox. 
Casale et al. ( 1984) demonstrated that mul tidose 
administrations of a highly oxygenated perfluorocarbon ( PFC) 
cardioplegic solution ( po2 590 mmHg, 17°c) prevented the 
development of oxygen free radical perfusion injury, as 
against a PFC solution with only 150 mmHg oxygen. Maintenance 
of high oxygen in the tissue by the cardioplegic solution was 
therefore found to be beneficial. The addition of free radical 
scavengers in the highly oxygenated PFC solution did not 
increase the recovery of the hearts, al though there was an 
improvement when they were added to the low po 2 solution. 
However, the solution used in this study was Fluosol - DA, 
which has a different ionic composition to the ST No 2 
solution. With oxygenation of the ST No 2 solution, free 
radical activity may have been present with a high pH, but was 
indeed reduced with a low pH and oxygenation. Increased energy 
production by oxidative phosphorylation may also play a role 
in inhibiting free radical formation while the prevention of 
intracellular Ca 2+ accumulation by a low pH may also reduce 
the predisposition of the myocardium to the oxygen paradox. 
The ST is cheaper and easier to use than the perfluorocarbon 
solution, and when gassed with 95%02 5%C02 , resulted in very 
good recoveries. There does not seem to be any need for the 
use of the PFC solution. 
iv) Disadvantages of oxygenation 
There are practical disadvantages associated with the addition 
of oxygen to a solution, especially at a high partial 
pressure. Gassing of the cold cardioplegic solution at a high 
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po2 leads to the gas coming out of solution at warmer 
temperatures. Bubbles were seen to form in the intervals 
between flushes in the tubing leading from the vessel storing 
the cardioplegic solution at 10°c, as the tubing was not kept 
cold. These .bubbles can lead to the formation of emboli in the 
coronary vasculature which predispose to myocardial damage. 
This problem may be avoided by gassing the solution at warmer 
temperatures than that at which it is to be used, although a 
reduction in oxygen content would result. The temperature of 
the solution infused into the hearts with a high po2 may also 
be altered. 
pH of a solution is determined by the pco 2 according to a 
derivation of the Henderson-Hasselbalch equation 
pH= pK + log [HC03-J/0.03 x pC02 
where O. 03 1s the Bunsen solubility coefficient of co2 . The 
pco2 1s in turn affected by the degree of oxygenation of a 
solution (Table 6). The changes in pH with different gassing 
over the range of temperatures at which the cardioplegic 
solution may be used were determined. The Rosenthal correction 
factors for the different solutions were obtained from the 
slopes of the graphs. The pH of the solution gassed with 95%0 2 
5%Co2 was stable over the range of temperatures measured. As 
temperature decreases, there is an increase in the solubility 
of co2 , and therefore an increased content in the solution 
which is constantly bubbled. The pH is thus reduced by this 
increase in co2 despite the effect of temperature on the 
dissociation of the protons. There was thus greater stability 
of pH with a change in temperature. This 1s a valuable 
property of the solution, especially considering the changes 
in temperature which occur in the use of a solution during an 
operation. This may allow a certain flexibility in the 
temperature at which the hearts are maintained. A practical 
advantage of this would be prevention of gaseous emboli. 
An alternative would be to reduce the o 2 partial pressure 
obtained. The uptake of oxygen from the solution by our hearts 
accounted for only 40%-45% of that provided, although uptake 
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may be dependent on the gradient of oxygen. In our studies, 
the po2 's of the oxygenated solutions kept at 10°c were very 
high, in the region of 600-650 mmHg. While this was beneficial 
to the hearts, especially at a low pH, the p02 's of the 
ST+Glucose solution open to atmosphere (see above) were lower, 
ranging from about 150-400 mmHg, but the results were similar 
to those attained above. 
Extrapolation from the work of de Wit et al. (1988) suggests 
that a partial pressure of at least 450 mmHg is required. The 
effects of differences in oxygen tension of a cardioplegic 
solution (mmol/1 - Na+ 130, K+ 30, ca 2 O, glucose O, pH 7.4) 
were investigated. 5% co2 was used together with 30%, 60% and 
95% o 2 , and the balance made up with nitrogen. The partial 
pressures of oxygen were 193, 308 and 473 mmHg respectively. 
The temperature of the hearts was maintained at 20°c, and 
multiple infusions of the solution were administered over an 
arrest period of.~ hours. Oxygenation improved the functional 
recoveries in all cases, but maximal recovery was seen with 
95% o 2 . The addition of glucose and insulin to the solution 
with 95% o 2 had no effect on functional recovery. The solution 
used in this study was possibly inferior to the ST solution, 
especially as no calcium was included. The temperature used in 
these studies was higher than that in our experiments, which 
affects the oxygen content of the solutions. The optimal po2 
for a cardioplegic solution therefore still remains open to 
investigation. 
The use of an oxygenated solution at a warmer temperature may 
also help to prevent emboli formation. Coetzee et al. ( 1986) 
determined the effect of oxygenation in a cardioplegic 
solution (mmol/1 - Na+ 130, K+ 30, Hco 3- 28, ca2+ o, pH 7.4) 
at different temperatures using the working rat heart model. 
Nonoxygenated (po 2 117 mmHg) and oxygenated solutions (po 2 440 
mmHg) were compared at 4°c and 20°c. After 2 hours arrest, 
better preservation of ATP was observed for the oxygenated 
cardioplegic solution group at the lower temperature, but no 
differences in functional recovery were observed. At 20°c, 
oxygenation of the solution was found to increase high energy 
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phosphate levels and functional recovery with a significant 
correlation between these variables. Temperature of the 
cardioplegic solution is therefore important when considering 
the inclusion of o 2 . 
v) Conclusions 
The provision of oxygen at high partial pressures during 
multi dose cardioplegia is feasible in the face of the above 
problems, and of significant benefit to the hearts. The 
question does remain as to whether such a high po2 is 
required, as 
the initial 
when comparing this series of 
study, the results attained 
experiments with 
with the ST+G 
(aerated) and when gassed with 95%02 5%C02 are similar. 
However, it must be stressed that the former solution did 
contain oxygen at variable partial pressures, while the pH 
ranged from 7.4 8.0. Thus there is a large degree of 
variation in the solution used. It was decided to try and 
clarify the situ~tion by determining the more advantageous 
range for these variables. This study attempts to give the 
direction for further research into the exact value of these 
variables. Emphasis is also placed on the beneficial effect of 
gassing the solution. This is not often done in the clinical 
situation, where the solutions used are commercially 
manufactured and stored in sterile, non-gassed bottles. The 
advantages of gassing the solution, preferably with 95%0 2 
5%C02 , are stressed. 
Although these results indicate the beneficial effects of 
oxygenation with 95%02 5%co2 of the ST+G solution used 
intermittently during arrest, when considering storage of 
transplanted hearts, a single dose of 
supplied, and the heart is then 
cardioplegic solution is 
stored hypothermically. 
Further oxygen is not provided during arrest. Other, more long 
term, strategies must be investigated to improve the 
preservation of stored hearts, although results of the above 
experiments may be applied 
The buffering capacity of the ST+Glucose solution was not very 
high and may perhaps be increased to allow better preservation 
of hearts with long term storage. 
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C. Buffering of the ST+Glucose solution with single dose 
cardioplegia 
a) Introduction 
The provision of glucose as a substrate in the ST solution 
used with a single dose protocol was not deleterious. However, 
an increased glycolytic flux may compound the intracellular 
acidosis which develops during an ischaemic period (Tsien, 
1976; Case et al., 1979; Cobbe and Poole-Wilson, 1980a). While 
a small reduction in pH may be protective to a degree (Bing et 
al., 1973; Nayler et al., 1979), extreme acidosis is 
associated with cellular damage and necrosis. This may counter 
any positive effect of elevated glucose on energy production 
during the early arrest period, especially if the duration of 
arrest is extended. While intermittent flushing removes 
accumulated metabolites, with long term preservation of donor 
hearts, this is impractical. An alternative is improved 
buffering of the protons, either in the cell or in the 
extracellular medium, which may inhibit the development of 
extreme acidosis and associated injury to the cells and 
thereby extend the duration of arrest. Prevention of extreme 
acidosis may reduce the inhibition of glycolysis, thereby 
enhancing energy production via this pathway. 
The choice of buffer to add to a cardioplegic solution is 
important. The buffer must be physiological with a high 
buffering capacity in the critical pH range required for 
optimal preservation of the arrested myocardium (Bretschneider 
et al., 1984). Histidine is an important physiological buffer, 
and has a strong buffering capacity. It has been used by 
Bretschneider's group in Germany in the formulation of their 
HTK cardioplegic solution (Bretschneider et al., 1984). At a 
concentration of 198 mmol/1, this is the major component of 
their so-called "intracellular" solution, which has a low Na+ 
concentration to prevent development of an action potential, 
and no ca 2+ to suppress contraction of the myofibrils 
(Bretschneider et al., 1975). These reductions in Na+ and ca2+ 
also create the osmotic space for the addition of oistidine. 
The rationale for the high buffering capacity · is to improve 
the metabolic energy gain by preventing inhibition of 
glycolysis (Bretschneider et al., 1984). The criteria used for 
determining the effectiveness of the HTK solutions is the 
duration of arrest until the ATP levels reach a minimum of 4 
µmol ATP/g wet weight. This time is extended by the use of a 
highly buffered solution. As this reflects our aim of 
extending the time of arrest of donor hearts for 
transplantation, we wished to test this principle of increased 
buffering capacity in the isolated working heart model with a 
single initial dose of cardioplegic solution. 
The addition of histidine in a multidose protocol may also be 
beneficial but with the present model, recoveries of 87% 
aortic output for mul tidose ST+Glucose, and 89% when gassed 
with 95%0 2 5%C0 2 could not really be improved upon. In order 
to see any significant effects with histidine, we used a 
single dose protocol, especially as buffering may be a long 
term strategy. The aim of our study was to improve 
preservation of donor hearts for long distance procurement. It 
was therefore felt that the single dose protocol was 
appropriate. 
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b) Experimental Procedure 
The inclusion of a buffer in significant amounts increases the 
osmolarity of the cardioplegic solution (Bretschneider et al., 
1984). As we wished to add 50 mmol/1 histidine, the same 
amount of sucrose was added to the ST+Glucose solution for a 
separate control group, to test the effect of an increase in 
osmolari ty on recoveries of hearts after 3 hours arrest at 
10°c. In addition, the Na+ concentration was reduced by 
20 mmol/1 to increase osmotic space, and tested with the 
addition of 50 mmol/1 sucrose to the solution. This solution 
would then have a similar osmolarity to the normal ST+Glucose 
solution. Sucrose increases the osmolari ty of the solution 
without any physiological effects. The use of 100 mmol/1 Na+ 
has been shown to have no effect on recoveries of the hearts 
( Jynge, 1980) . The compositions of the solutions tested are 
shown in Table 10, together with the calculated osmolarities. 
Histidine was added at two concentrations ( 50 and 80 mmol/1) 
to the ST+Glucose solution with a reduced Na+ concentration, 
to obtain a dose response curve. 
The presence of a strong buff er may alter the optimal pH of 
the cardioplegic solution. With a protocol of intermittent 
washout, a more acidotic 
intra- and extracellular 
critical level. However, 
solution appears to beneficial, as 
pH can be maintained at a fairly 
without intermittent flushing, a 
higher pH of the cardioplegic solution may be more beneficial, 
as a lower pH will precipitate the development of extreme 
acidosis. The pH of the histidine-containing solution was 
altered by removing the bicarbonate, inducing metabolic 
acidosis. 
The, Bretschneider's HTK solution was compared to the 
histidine-containing ST+Glucose solution in the present model, 
in order to determine the relative efficacies of these two 












































































































































































































































































































































































































































































































































































































i) Effect of increased osmolarity and decreased 
concentration of the ST+Glucose solution used with a single 
dose 
Pre-ischaemic control values were compared between groups, and 
no significant differences were found. The functional 
recoveries obtained by adding 50 mmol/1 sucrose to the 
ST+Glucose solution showed no differences from the standard 
solution, whereas decreasing the Na+ concentration with 
osmolarity maintained had a slightly negative effect on 
overall recovery, although of no significance. Percentage 
recoveries for these groups were in the range of 55-65% (Table 
11). There was a significant difference in cardiac output 
between the increased osmolarity and the decreased sodium 
group (75.9 ± 3.7 % vs 67.1 + 2.0 % respectively, p<0.05). 
Coronary flows on reperfusion were slightly greater 1n the 
increased osmolarity group (14.5 ± 0.9 ml/min) compared to the 
control group (12.8 ± 1.3 ml/min) (Table 12). This effect may 
have been due to lower prearrest values 1n the increased 
osmolarity group, although these were not significant. The 
results may not indicate any real difference between the 
groups. 
LDH washout on reperfusion after use of the increased 
osmolarity ST+Glucose cardioplegic solution was significantly 
increased compared to that with the standard solution, with 
103.6 ± 7.1 mU/gm/min compared to 66.7 + 7.5 mU/gm/min 
(p<0.002) (Table 12). This effect was not seen with the 
decreased Na+ group. Lactate production was highest in the 
former group as well (Table 12). These factors suggest that a 
higher osmolarity and a high Na+ have side effects which 
negate the slightly higher recoveries obtained. ATP' s were 
significantly reduced compared to control levels (p<0.02). 
CP's were also lower than control levels, but not 
significantly so (Table 13). 
It was felt that enough osmotic space was made available by 
the removal of 20 mmol/1 Na+ without compromising the 
110 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 13: Means ± sem of tissue levels of adenosine 
triphosphate (ATP) and creatine phosphate (CP) of control 
hearts clamped after 10 minutes work before arrest, and of 
arrested hearts after 20 minutes reperfusion. Comparison of 
hearts arrested with St Thomas' Hospital cardioplegic solution 
No. 2 with llmmol/1 glucose ( ST+G), and with alterations in 
sodium concentration and osmolarity. The arrested hearts were 
stored for 3 hours at 10°c. 
ATP CP 
(µmol/gm) (µmol/gm) 
Control 3.9 ± 0.3 5.1 ± 0.5 
(n=6) 
ST+G 2.3 + 0.1 * 4.2 ± 0.2 
(n=9) 
Iner Osm 2.5 ± 0.1 * 3.9 ± 0.6 
(n=4) 
* p<0.02 vs control 
ii) The addition of histidine to the ST+Glucose solution 
Histidine was added at a concentration of 50 mmol/1 to the 
ST+Glucose solution with a reduced Na+ concentration. This led 
to a marked improvement of recovery after three hours single 
dose arrest compared to both the normal ST+Glucose solution 
and that with altered osmolarity and Na+ levels, with 
percentage recoveries of aortic output of 76.1 ± 3.4 % 
(p<0.05) (Table 14). 
Measurement of the coronary flows on reperfusion showed no 
change with the presence of 50 mmol/1 histidine compared to 
both control groups (Table 15). LDH washout on reperfusion was 
reduced with the addition of 50 mmol/1 histidine to the 
ST+Glucose solution, at 49.5 + 3.9 mU/gm/ml (Table 15), 
compared to the control solutions. 
Lactate efflux on reperfusion was slightly increased in the 
presence of histidine (Table 15). However, ATP and CP levels 
were no differenf from those with the other cardioplegic 
solutions (Table 16). The level of ATP was significantly lower 
than in pre-ischaemic heart tissue. 
A higher concentration of histidine (80 mmol/1) was tested to 
see if functional recoveries could be improved upon, but the 
opposite effect was seen (Table 14). A depressed recovery of 
function of only 54.7 ± 3.3 % for aortic output resulted, even 
lower than control values, especially compared to the 
increased osmolarity solution (65.5 ± 5.8 %) (Table 11), which 
had a similar osmolarity. The 80 mmol/1 histidine solution 
resulted in a 2. 5 fold increase in LDH output against the 
50 mmol/1 histidine solution (129.1 ± 23.5 mU/gm/ml) (p<0.05) 
(Table 15), and a decline in lactate output of 50% (Table 15). 
Coronary flow was, however, slightly increased versus the 
50 mmol/1 histidine group (15.4 ± 0.8 ml/min versus 13.7 ± 0.4 
ml/min) (Table 15). Tissue ATP and CP levels showed no 
differences between the two groups although ATP was 
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Table 16: Means ± sem of tissue levels of adenosine 
triphosphate. (ATP) and creatine phosphate (CP) of control 
hearts clamped after 10 minutes work before arrest, and of 
arrested hearts after 20 minutes reperfusion. Comparison of 
hearts arrested with St Thomas' Hospital cardioplegic solution 
No. 2 with llmmol/1 glucose with a decrease in sodium 
concentration with the addition of 50mmol/l (Hist 50) or 
80mmol/l histidine ( Hist 80), and the addition of 50mmol/l 
histidine with the removal of Hco 3- (Hist 50, No Hco3-). The 
arrested hearts were stored for 3 hours at 10°c. 
ATP CP 
(µmol/gm) (µmol/gm) 
Control 3.9 ± 0.3 5.1 + 0.5 
(n=6) 
Hist 50 2.3 ± 0.2 * 3.5 ± 0.5 
(n=8) 
Hist 80 2.3 ± 0.1 * 4.4 + 0.3 
(n=7) 
Hist 50 2.7 ± 0.2 * 4.2 ± 0.1 
No HC0 3 
-
(n=6) 
* p<0.02 vs control 
iii) Removal of Hco3- from the histidine-containing ST+Glucose 
solution 
The effect of a lower pH in the presence of histidine was 
tested by removing the Hco 3- from the solution, which leads to 
a metabolic acidosis. The pH of the ST+Glucose solution with 
histidine but lacking Hco 3-, gassed with 95%0 2 5%co 2 on 
preparation, was 7.05 ± 0.02, compared to the pH of the 
50 mmol/1 histidine solution, of 7.3 ± 0.02, and the 
ST+Glucose control solution, of 7.4 ± 0.1 (Table 10). 
The recovery of the hearts with this solution was seen to 
decrease to 52. 7 ± 4. 0 % for aortic output ( p<O. 01 versus 
50 mmol/1 histidine group) ( Table 14) . The least lactate was 
produced with the O mmol/1 HC03- group, and a relatively high 
LDH efflux was present (97.1 ± 22.8 mU/gm/min) (Table 15). 
This corresponded to a high coronary flow which was 
significantly greater than those of the 50 mmol/1 histidine 
and the increased.osmolarity, standard Na+ groups (16.9 ± 0.7 
ml/min) (Table 15). 
ATP and CP levels were not significantly different against the 
other groups or against control values (Table 16). The ATP was 
the highest of all values attained in the above experiments, 
but was correlated with the lowest recovery, as were the 
relatively high CP levels. 
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iv) Properties of the histidine-containing ST+Glucose solution 
a) pH and temperature curves 
The change in pH with a reduction in temperature of the 
50 mmol/1 histidine solution was parallel to that of blood, 
with Rosenthal correction factors of -0.0143 and -0.0147 
respectively (Figure 15). 
b) Titration curves and buffering capacities 
Titration curves for the standard ST+Glucose solution, and the 
ST+Glucose solutions with 50 mmol/1 histidine, 80 mmol/1 
histidine or 50 mmol/1 histidine, O mmol/1 HC03 - were 
determined, and the derivatives for these curves calculated. 
These are shown in Figures 16 and 17. The maximum buffering 
capacity with 80 mmol/1 histidine was found to be 
50 mmol HCl/1/pH, and -30 mmol HCl/1/pH with 50 mmol/1 
histidine and 50 mmol/1 histidine/No HC03- at pH's from 6.1 to 
6.3. At pH 7, the buffering capacity of the 50 mmol/1 
histidine containing solution was still relatively high, at -
10 mmol HCl/1/pH, while that of the ST+Glucose solution was 
about -4 mmol HCl/1/pH. The histidine-containing solution was 
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Fig. 15. Change in pH with temperature of the St Thomas' 
Hospital cardioplegic solution No. 2 with 11 mmol/1 glucose 
(ST+G), and with the addition of 50 mmol/1 histidine, compared 
to blood. The solutions were continually gassed with 95%02 
5%C02 . 
Slop~s of the curves give the Rosenthal correction factors. 
ST+G -0.0220 
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Fig. 16. Titration curves of the St Thomas' Hospital 
cardioplegic solution No. 2 with 11 mmol/1 glucose (ST+G), and 
with the addition of 50 mmol/1 or 80 mmol/1 histidine, and the 
addition of 50 mmol/1 histidine in the absence of Hco3-. The 
solutions were continually gassed with 95%02 5%co2 at room 
temperature. The inflection points give the pK's for the 
solutions. 
ST+G 6.2 
ST+G+50 mmol/1 Histidine 6.1 
ST+G+80 mmol/1 Histidine 6.3 
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Fig. 17. Buffering capacities of the St Thomas' Hospital 
cardioplegic solution No. 2 with 11 mmol/1 glucose (ST+G) 
gassed with 95%0 2 5%co 2 , and with the addition of 50 mmol/1 
and 80 mmol/1 histidine, and the addition of 50 mmol/1 
histidine in the absence of Hco3-. The solutions were 
continually gassed with 95%02 5%co2 at room temperature. 
Buffering capacity is expressed as the instantaneous 
(derivative) slope of the titration curves (Fig. 16). 
8 
v) Bretschneider's HTK cardioplegic solution versus the 
ST+Glucose and the ST+Glucose+histidine solution 
Bretschneider' s HTK cardioplegic solution was used to arrest 
the hearts, which were then stored for 3 hrs at 10°c. The 
composition of this solution is shown in Table 17. Functional 
recoveries were comparable to those with the ST+Glucose 
solution (55.2 ± 3.4 % aortic output) (Table 18). However, LDH 
efflux was greater than the standard ST+Glucose solution 
(110.6 ± 15.6 mU/gm/min) (p<0.02) (Table 19). Lactate output 
was similar in the two groups (Table 19). The ST+Glucose 
solution was slightly better than Bretschneider's solution in 
the isolated working rat heart model. This may be because of 
species differences, where Bretschneider and colleagues have 
used the in vivo dog heart model, al though it is suggested 
that the Bretschneider's solution is not as good as the 
ST+Glucose solution, as its composition follows that of an 
"intracellular" solution. 
When compared to the 50 mmol/1 histidine ST+Glucose solution, 
the recoveries using Bretschneider's solution were found to be 
significantly lower ( p<O. 05) . Lactate output was lower than 
with 50 mmol/1 histidine, while LDH washout was significantly 
higher ( p<O. 001). Thus with an increased buffering capacity, 
ST+Glucose+50 mmol/1 histidine was markedly better than 
Bretschneider's HTK solution. 
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Table 17: Composition of St Thomas' Hospital cardioplegic 
solution No. 2 with llmmol/1 glucose and 50mmol/l histidine 
(ST+G+histidine) and Bretschneider's HTK solution (in mmol/1) 

























































































































































































































































































































































































































































Table 19: Means ± sem of coronary flow (CF), and average washout of lactate dehydrogenase 
(LOH) and lactate· during 10 minutes reperfusion in the Langendorff mode (Post-arrest), and of 
tissue levels of adenosine triphosphate (ATP) and creatine phosphate (CP) of hearts after 20 
minutes regerfusion. Hearts were arrested with Bretschneider's HTK solution and stored for 3 





10.6 ± 1.9 
$ p<0.02 vs ST+G 
Post-arrest LOH 
(mU/gm/ml) 
110.6 ± 15.6 $& 
& p<0.001 vs Hist 50 Deer Na+ 
* p<0.03 vs control 
Post-arre~t Lactate 
(µmol/gm/min) 
0.9 ± 0.5 
ATP 
(µmol/gm) 
1.8 ± 0.03 * 
CP 
(µmol/gm) 




vi) Titration curve and buffering capacity of Bretschneider's 
solution 
The titration curve (Figure 18) and buffering capacity (Figure 
19) for the Bretschneider's solution was compared to the 
ST+Glucose with 50 mmol/1 histidine solution. Because of the 
high histidine concentration in the Bretschneider's solution, 
the buffering capacity is very large, -40 
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Fig. 18. Titration curves of the st Thomas' Hospital 
cardioplegic solution No. 2 with 11 mmol/1 glucose and 50 
mmol/1 histidine, and Bretschneider's HTK solution. The 
solutions were continually gassed with 95%0 2 5%co 2 at room 
temperature. The inflection points of the curves give the pK's 
for the solutions. 
ST+G+50 mmol/1 Histidine 6.1 





















Fig. 19. Buffering capacities of 
cardioplegic solution No. 2 with 
the St Thomas' Hospital 
11 mmol/1 glucose and 50 
mmol/1 histidine, and Bretschneider's HTK solution. Buffering 
capacity is expressed as the instantaneous (derivative) slope 
of the titration curves (Fig. 18). 
d) Discussion 
i) Histidine 
Histidine is an amino acid with an imidazole side chain group 
which confers strong buffering properties at physiological 
pH's. The structure of histidine is shown in Figure 20. As the 
temperature decreases, it is the imidazole moiety which is 
physiologically significant as it acts as a buffer with 
characteristics of a shift to alkalinity with hypothermia 
(Reeves et al., 1976). Although histidine is an amphoteric 
molecule, as are other amino acids, it is the pK of the 
imidazole moiety which is closest to physiologically important 
ranges of pH. The pK of this group changes with temperature in 
almost the same way as pKw (the dissociation constant of 
water), allowing histidine to retain its buffering capacity at 
all temperatures (Swan, 1984). 
Histidine is found in great abundance in haemoglobin where it 
is responsible for the transmission of structural changes in 
the heme group on the binding of oxygen (Metzler, 1977). 
Histidine residues are thought to be responsible for the Bohr 
effect, where the presence of H+ and co2 promote the release 
of o2 from the haemoglobin molecule. Histidine is also present 
in other blood proteins, where, as the principal ti tratable 
group, its buffering capacity is expressed. The total 
concentration in blood is about 30 mmol/1 (Swan, 1984). 
Histidine 
carnosine 
in muscle is usually 
(B-alanyl-L-histidine), or 
present as a dipeptide 
the bulk are in peptide 
linkage in proteins. Total buffering by histidine in striated 
muscle has been calculated at 80% of the total capacity (Abe 
et al., 1985). 
ii) Myocardial buffering 
During ischaemia, the cytosol becomes acidic because of 
increased glycolysis and inhibition of oxidative 
phosphorylation (Rovetto et al., 1975). The cell has various 
mechanisms to reduce the intracellular acid load. The primary 
mechanisms include intracellular buffering, which has been 















Fig. 20. Structure of histidine showing imidazole group with 
the basic site which can accept a proton to form a conjugate 
acid. The histidine residue is found 1.n the active sites of 
many enzymes because of this R group. 
ventricle cells (Roos and Boron, 1981). Intracellular hydrogen 
ions are buffered by phosphates, mitochondria, the 
sarcoplasmic reticulum, and the histidine residues of the 
proteins (Poole-Wilson, 1989) . However, these mechanisms are 
not always sufficient to deal with the excess protons 
produced. These protons can be extruded together with lactate, 
or in exchange for sodium, thought to be a major mechanism of 
pH regulation (Vaughan-Jones, 1988). 
Correct buffering is important in maintaining Donnan ratios 
across the cell membrane as well as cell volume (Rink, 1984), 
and may determine the degree of oedema on reperfusion of the 
arrested hearts (White, 1981). The presence of large 
intracellular impermeant anions leads to a greater 
intracellular buffering capacity compared to the extracellular 
space (Roos and Boron, 1981; Rink, 1984). This increase the 
intracellular pH as calculated from the Donnan equilibrium, 
from pHi of 5.7 t~ approximately 7.0, thereby reducing the pH 
gradient, with pH 0 of 7.4 (Roos and Boron, 1981). A large 
increase in intracellular acidosis affects the valency of 
these large impermeant solutes, which in turn affects the el-
and K+ fluxes across the cell membrane (Rink, 1984). If Cl-
enters the cell down its concentration gradient following K+ 
loss, especially in ischaemia, this will draw in both Na+ and 
water, with cellular swelling. Cl- is also exchanged for Hco3-
across the membrane, which may increase intracellular acidosis 
(Vaughan-Jones, 1988). 
iii) Buffering during cardioplegic arrest 
The addition of 50 mmol/1 histidine to the ST+Glucose solution 
was advantageous to the hearts arrested with a single dose of 
cardioplegic solution. The recoveries of the hearts after 
three hours arrest at 10°c were significantly increased, while 
LDH washout on reperfusion was reduced and lactate efflux was 
relatively higher. 
The addition of a buffer to a cardioplegic solution has been 
suggested to prevent a decline in pH (Vander Woude et al, 
1985) , with reduced inhibition of glycolysis ( Bretschneider, 
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1980) and other enzymatic pathways, as enzymes are highly 
dependent on pH for their optimal activity. Preservation of 
myocardial ATP stores has been found ( del Nido et al, 1985) 
with increased metabolic efficiency and greater energy 
production per mole of substrate utilised. 
Choice of a buffer to add to a cardioplegic solution rests on 
the characteristics of that buffer. The optimal buffering 
power, which is usually at its pK, must be within the 
physiological range of pH, and preferably close to that 
considered ideal for cardioplegic arrest. A lower pH than 
would normally be present in the extracellular solution has 
been found to be beneficial ( Bernard et al. , 1985) , and a 
buff er with a pK in this range would be best. The pK' s and 
changes in pH with a change 1n temperature for various 
physiological buffers are shown in Table 20. 
Kresh et al. ( 1987) determined the relative buffering powers 
of bicarbonate .and tromethamine-based (THAM) crystalloid 
cardioplegic solutions, and a histidine-buffered solution 
(Bretschneider's HTK 198 mmol/1 histidine). The values 
obtained are shown in Table 21. The buffering power of the 
histidine-containing buffer was far greater than the 
bicarbonate or THAM cardioplegia. Thus protein buffers may be 
more beneficial than the bicarbonate buffer system, especially 
as the buffering power of homogenised myocardial tissue at -
40 mmol HCl/1/pH is closer to that of histidine and maximal at 
similar pH's (Kresh et al., 1987). Histidine is therefore a 
more physiological buffer. 
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Table 20: Characteristics of physiological buffers compared to 
blood and water - pK' s and coefficient of change in pH with 
change in temperature (Rosenthal correction factors). 
pK opH/o 0 c 
(25°C) 
Histidine 
- aCOOH 1.82 
- aNH+ 9.17 
- Imidazole 6.0 
- total 6.7 -0.022 
Bicarbonate 6.35 -0.005- -0.010 
Phosphate 6.9 -0.003 
Blood 7.4 -0.0147 
(37°C) 
Water -0.017 
Table 21: Range of buffering capacities at 27°c of 
cardioplegic solutions with different buffers at physiological 
pH's (pH 6-8) (maximum buffering capacity is at the pK for the 
buffer - see table 20). The buffering capacity of a myocardial 














a Kresh et al., 1987 
b Roos and Boron, 1981 
Buffering capacity 
(mmol HCl/1/pH) 
-2 - -15 
-1 - -15 
-25 - -60 
-30 
-40 









The buffer added to the cardioplegic solution may act intra-
or extracellularly, depending on its ability to be taken into 
the cells. The addition of phosphate buffer in the 
extracellular medium has been shown to increase proton flux by 
up to fourfold (Roos and Boron, 1981). Vanheel et al. (1985) 
showed that buffering of the superfusate of an isolated 
papillary muscle preparation prevents intracellular acidosis 
by reduction of surface acidification. With a buffer in the 
extracellular medium, protons will be extruded together with 
lactate, resulting in a greater efflux of lactate with a 
higher buffering capacity. With 50 mmol/1 histidine in the 
ST+Glucose solution, lactate efflux on reperfusion was 
increased compared to the control groups, possibly by this 
mechanism. If the buffer enters the cells, intracellular 
buffering will affect intracellular pH more directly, and 
inhibit proton flux across the membrane. This may reduce 
subsequent intracellular Na+ overload, which has been linked 
to ca 2+ influx on·reperfusion. However, the two mechanisms of 
the action of a buffer are contradictory. Whether a buffer is 
taken up into the cells or not may determine the mechanism of 
its action. Histidine has been shown to be transported into 
the hepatocyte via a Na+-dependent (System N) and a Na+-
independent (System L) carrier mechanism (Kilberg et al., 
1980; Christensen, 1984; Leonardi et al., 1988). This may also 
occur in the myocyte, although the rate of uptake is possibly 
reduced because of differences between liver and heart 
metabolism. This rate will also be substantially reduced by a 
decrease in temperature and inhibition of metabolism and a 
decrease in the Na+ gradient. With time there will be 
increased intracellular proton accumulation, but the rate of 
histidine entry into the cell, while slow, may be enough to 
combat the development of an extreme acidosis, and the 
possible build up of a proton gradient. A mild intracellular 
acidosis would appear to be beneficial, but not too extreme 
( see above) . A slower rate of entry of histidine into the 
cell, instead 
development of 
of a rapid influx, will also 
cellular oedema by the osmotic 
inhibit the 
movement of 




is no intermittent washout 
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of accumulating 
iv) Bretschneider's solution versus ST+G+histidine 
A comparison of multidose usage of a crystalloid bicarbonate 
containing cardioplegic solution, blood cardioplegia, and 
Bretschneider's solution buffered with histidine, was made 
(Tait et al., 1982). The greater buffering capacity of 
histidine was advantageous in increasing the glycolytic rate 
and preventing a drop in pH. A greater washout of lactate with 
the Bretschneider's solution was found. The use of a 
crystalloid cardioplegic solution with low buffering capacity 
was found to be unable to prevent progressive tissue acidosis 
to about 6.6 after 3 hrs arrest, while Bretschneider's 
solution and blood cardioplegia prevented a reduction in 
tissue pH below 7.2. With the higher tissue pH maintained at 
about 7.2, glycolysis is not greatly inhibited, while 
increased extracellular buffering will also increase the flux 
of lactate and protons across the membrane by maintaining the 
pH gradient (Vaughan-Jones, 1988). 
Several disadvantages of the Bretschneider's solution have 
been observed. Bretschneider's solution proved the least 
effective in inducing and maintaining electromechanical arrest 
(Tait et al., 1982) while the lack of calcium is thought to 
predispose to the ca 2+ paradox (Ruigrok et al., 1983). While a 
lower temperature is thought to inhibit the appearance of the 
ca 2+ paradox when using this solution (Bretschneider et al., 
1984), the addition of 50 µmol/1 ca 2+ to Bretschneider's 
solution was found to improve recovery (Ruigrok et al., 1983), 
possibly by depressing excess ca 2+ influx on reperfusion. 
Although the use of a low temperature may inhibit the 
occurrence of this phenomenon, it does limit the use of the 
solution. 
In comparison to the ST+G solution, Bretschneider's 
formulation was as effective in the isolated rat heart model. 
However, when the ST+G solution was additionally buffered with 
histidine, the latter was far more efficacious. Intracellular 
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solutions do not appear to work well in the rat heart 
(unpublished observations), and the difference in animal 
models used, between this and other studies, may account for 
the differing observations. However it is believed that the 
extracellular formulation of the ST solution is better than 
the intracellular formulations, as there is less manipulation 
of the ionic gradients and less perturbation to the 
myocardium. 
v) Concentration of histidine in the ST+Glucose cardioplegic 
solution 
A higher histidine concentration of 80 mmol/1 in the 
depress ST+Glucose cardioplegic solution was found to 
recoveries to below those found with the standard ST+Glucose 
solution. This may have been due to an osmotic effect, 
although this was tested for with the solution containing 50 
mmol/1 sucrose and 120 mmol/1 Na+, which had a slightly higher 
osmolarity, but better recoveries. These results are 
unexplained as the Bretschneider' s solution uses a very high 
histidine concentration of 198 mmol/1. Del Nido et al. (1985) 
also found a beneficial effect of 195 mmol/1 histidine in a 
low Na+, high glucose (83 mmol/1) solution with a relatively 







and histopathological assessments 
reduced necrosis with improved 
contractile recovery, and better preservation of high energy 
phosphate stores with buffering. However, with a high K+ (30 
mmol/1) and buffering, recoveries were reduced compared to 
those of the unbuffered solutions, either with 10 mmol/1 or 30 
mmol/1 K+. The explanation for these findings was that with 
the high pH of the solution, a depolarisation of the resting 
membrane potential with a high K+·and the absence of ca2+ led 
to the ca2+ paradox phenomenon. The interaction of the various 
ionic components of the cardioplegic solution was emphasised, 
and may explain the variability in results with differing 
extracellular buffering capacities. 
Bretschneider' s solution and that used by Del Nido et al. 
(1985) both have a low Na+ concentration and no ca 2+, compared 
to the high Na+, ca2+ containing ST+Glucose solution. 
Histidine transport into the cell is partially dependent on 
the Na+ gradient, and its entry may be inhibited with a low 
extracellular Na+. This may prevent excess influx of a large 
molecule into the cytosol with osmotic effects. The benefits 
of increased extracellular and intracellular buffering with a 
higher histidine concentration of 80 mmol/1 may be outweighed 
by these effects. The results obtained with similar 
osmolarities with the sucrose containing solution may be 
because sucrose does not enter the cells, and therefore will 
not increase cellular oedema. However, this is contradicted by 
the results attained on reperfusion of the hearts, where 
coronary flow was significantly increased with the higher 
histidine concentration. There was also a significant increase 
in LOH efflux in the ST+Glucose+80 mmol/1 histidine group 
compared to the 50 mmol/1 histidine group. The sucrose 
solution with standard Na+ concentration also showed a higher 
LOH efflux and coronary flow compared to the ST+Glucose 
solution. An increased extracellular osmolarity will draw out 
fluid from the cells, increasing coronary flow because of 
shrinking of the cells. However, an increased intracellular 
oedema may also lead to an increased coronary flow on 
reperfusion because of breakage of cell membranes, especially 
of the endothelial cells. This was seen with an increased 
efflux of LOH in the 80 mmol/1 histidine group, and may have 
led to increased coronary flow on reperfusion, and an overall 
reduction in function. 
vi) Bicarbonate buffer system versus histidine 
Vander Woude et al. ( 1985) examined the effect of imidazole 
( 25 ,mmol/1) ( pK 6. 7 at 3 7°c) in an acalcaemic cardioplegic 
solution with a high Na+ and high K+. This was compared to a 
Hco 3- containing solution (25 mmol/1). The benefits of 
imidazole buffering were observed in increased functional 
recovery, and a higher pH of the coronary effluents with 
intermittent flushing. Vander Woude et al. ( 1985) wanted to 
exclude the effects of changes in pco2 on the bicarbonate 
buff er system. Imidazole buffering is not dependent on the 
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pco2 of the solution. The level of co2 in an ischaemic heart 
changes with time, altering the bicarbonate equilibrium, 
leading to acidosis. With longterm arrest, co 2 will be 
affected which will alter the buffering effect of the 
bicarbonate system. In addition, the pK of the bicarbonate 
system is 6.35 at 25°c (see Table 20) which is below that of 
optimal intracellular pH during arrest. These results indicate 
that Hco 3- in a cardioplegic solution is not necessary in the 
presence of a stronger buffer. 
However, in our results, an absence of Hco3- in the histidine 
containing ST+Glucose solution reduced recoveries, stressing 
the importance of this buffer. While buffering capacity is 
increased with histidine, the presence of HC03- may be 
required to prevent acidosis by accumulating co2 . Oxygen is 
present in the cardioplegic solution at a po2 of about 150 
mmHg (atmospheric po2 ) as it is open to atmosphere. There is 
also uptake of ?xygen from the atmosphere by the heart 
suspended during arrest. This oxygen will be metabolised with 
the production of co 2 . 
vii) pH and histidine 
Bernard et al. (1985) examined the effect of different buffers 
1n a crystalloid cardioplegic solution (mmol/1 Na+ 100, K+ 4, 
ca2+ 0.25, Mg2+ 13). Glutamate (20 mmol/1), Tris (47.5 
mmol/1) , bicarbonate ( 20 mmol/1) or histidine ( 64. 4 mmol/1) 
were added. The solutions were titrated to pH's of 7. 00 and 
7.4 at 20°c. In control hearts, treated only with hypothermia 
(15°C), a drop in pHi was found with time of arrest (2 hrs) 
from 7.1 to 6.13. With a pH of 7.4, bicarbonate in the 
cardioplegic solution was found to cause an increase in pHi 
over time to 7.32 with a multidose protocol. Histidine 
prevented a change in pHi from control values, while resulting 
in fastest recovery of function on reperfusion. No effect on 
high energy phosphate preservation was seen, with all hearts 
showing a decrease. 
However, with the solutions titrated to pH 7. 00, histidine 




with a poorer recovery in aortic flow compared to 
buffers. Thus a higher pH for the histidine-
containing solution is better. 
This was indirectly corroborated in the present study, as a 
decreased pH with 50 mmol/1 histidine with the induction of 
metabolic acidosis by the removal of HC03- reduced functional 
recovery. The pH of the 50 mmol/1 histidine solution was 
higher than that found to be optimal for multidose usage. 
With intermittent flushing of the heart, harmful metabolites 
are removed, and a decreased pH was advantageous to the 
myocardium (see above). The advantage of a relatively low pH 
would be to decrease enzyme activity and metabolic energy 
expenditure. However, if the metabolites are not removed, 
acidosis may increase to the extent that it becomes injurious. 
If the initial pH of the extracellular space is high, this may 
slow down the decline in pH by providing a larger gradient for 
proton efflux, while the increased buffering capacity with the 
addition of histidine also inhibits the development of 
acidosis (Tait et al., 1982; Bernard et al., 1985). 
The effects of histidine on glycolysis were observed in the 
reasonably high levels of lactate washout on reperfusion, 
indicating that inhibition of glycolysis by the accumulation 
of protons is decreased. Energy is possibly conserved with the 
inclusion of histidine as the pH is maintained at mildly 
acidotic levels. 
viii) Histidine as an oxygen quencher 
Protection of the membranes appears to be a major effect of 
histidine in preservation of the arrested hearts, as LDH loss 
on reperfusion was lowest with 50 mmol/1 histidine in the 
ST+Glucose solution. Histidine is a specific quencher of 
singlet oxygen and may thereby limit oxygen-induced cell 
damage on reperfusion (Gaudel and Duvelleroy, 1984). Singlet 
oxygen fragments the lipid hydroperoxides and reacts with 
unsaturated lipids of biomembranes, which may impair 
transmembrane ion movements. It is also associated with 
protein damage (Prinsze et al., 1990) leading to inactivation 
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of enzymes, increased susceptibility to proteolytic 
degradation, and modification of amino acid residues. Singlet 
oxygen is a prominent feature of the toxicity of molecular 
oxygen. The preservative effect of histidine is greater at the 
onset of reoxygenation than 10 min after, as it is suggested 
that a burst of free radical production occurs on 
reintroduction of o 2 (Bolli et al., 1989). 
ix) Conclusions 
The single dose protocol in the isolated working rat heart 
model is comparable to long term preservation of hearts for 
transplantation. When using the ST+Glucose+SO mmol/1 histidine 
solution, recoveries of about 76% aortic output after three 
hours arrest were obtained, compared to 61% with the standard 
ST+Glucose solution and 57% with ST. With longer periods of 
arrest, the inclusion of histidine may be of even more 
importance, as this may be a long term strategy. The inclusion 
of histidine in a multipurpose solution for use in both 
cardio-pulmonary bypass and donor heart storage must be 
investigated, al though the recoveries attained with gassing 




i) Clinical recommendations 
The aim of the study was to improve functional recovery of 
hearts after a period of arrest using a crystalloid 
cardioplegic solution. The results must be therefore be seen 
in the light of the clinical implications. The solutions 
devised on the basis of improved energy conservation were 
shown to lead to better functional recovery of the arrested 
hearts. Two possible alternatives were tested, and found to be 
applicable to different clinical usages. 
It is suggested that 
a) 11 mmol/1 glucose is added to the ST No 2 solution 
b) when used with intermittent flushing, the solution is 
gassed with 95%0 2 5%co 2 
c) the addition of histidine 
solution should be considered, 
storage. 
to the glucose-containing 
especially with long term 
The provision of 11 mmol/1 glucose in the ST No 2 cardioplegic 
solution resulted in significantly improved recoveries of 
arrested hearts when this effect was enhanced by intermittent 
removal of harmful metabolites. The presence of oxygen was 
found to be important at a low extracellular pH. However, with 
long term storage, a more stable mechanism for the inhibition 
of proton and lactate accumulation was found to be 
advantageous, with the addition of histidine as a buffer. 
The approach of increased energy production would seem to be 
valid on the basis of the above results, especially when this 
is optimised by use of various strategies to enhance energy 
conservation and production. This was the primary rationale 
behind the alterations to the ST solution that were made 
although other advantages were also seen such as preservation 
of the membranes. Further alterations to the solution based on 
this approach may lead to better long-term preservation of 
hearts for transplantation. However, direct ~linical 
extrapolation from these studies is inadvisable for several 
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reasons, including species differences, and limitations in the 
technique used. 
In extrapolating from these results, 
be considered. The solutions were 
the variables used must 
tested under specific 
conditions, and it is only under these circumstances that the 
use of these solutions can be fully recommended. Variables 
including temperature of the myocardium, and of the 
cardioplegic solution, duration of arrest, intervals between 




ii) Suggested strategies for the improvement of the ST 
solution 
The results obtained from oxygenation of the ST+Glucose 
cardioplegic solution, with a relatively low pH, and used in a 
mul tidose protocol of administration are possibly as good as 
can be obtained in the present model. This solution is simple 
to make and to administer with few disadvantages. However, 
additional changes to the solution for use with intermittent 
flushing cannot really be tested in our model, because of the 
high percentage recoveries attained. 
In the model of single dose administration of cardioplegic 
solution to the isolated rat heart, the presence of histidine 
was found to be advantageous. However, recoveries were still 
significantly depressed compared to pre-ischaemic control 
values. There may be additional advantages conferred, for 
example, by the addition of agents including additional 
substrates (Bernard et al., 1985; Rousou et al., 1986; 
Robinson et al., 1987), free radical scavengers (Gharagozloo 
et al., 1988; Jurmann et al., 1988; Chambers et al., 1989), 
channel blocking agents, oxygen carrying vehicles ( Kanter et 
al., 1981; Novick et al., 1985; Rousou et al., 1986; Tabayashi 
et al., 1988), and those which increase colloid and oncotic 
pressure (London et al., 1989; Marelli et al., 1989). A review 
of the literature listing the various possible interventions 
tested is given by McGoon (1985). 
Consideration of a different model for testing the various 
alterations to the solution suggested here must also be made. 
iii) Choice of model - advantages and precautions 
a) Species differences 
The choice of species used to test a cardioplegic solution has 
been debated (Bretschneider, 1980; Galinanes and Hearse, 
1990). While dogs are recommended by Bretschneider ( 1980), 
these animals are expensive and cannot be used in a series of 
experiments requiring large numbers of animals. The use of the 
rat model offers several advantages including availability of 
animals, simple experimental procedures without the need for 
sterile clinical conditions, reproducibility of experiments, 
and use of an isolated organ perfusion system with direct 
measurement of indices of function. For these reasons, in our 
experiments requiring large numbers of animals, we used the 
isolated rat model to test alterations to our solutions. These 
studies give an indication of the efficacy of the various 
formulations. However, there are differences between the rat 
and other animal . -species which must be taken into account. 
Because of these and other factors, the solutions must be 
tested in animal models which more closely resemble the human 
myocardium, with conditions similar to those in the operating 
theatre before extrapolating results to the clinical 
situation. 
1) Myocardial structure 
The rat myocardium is different 1n many respects from that of 
the human. Fundamental differences include metabolic rate, 
contractile performance, enzymatic functioning, and 
electrophysiological characteristics ( Bretschneider, 1980; 
Galinanes and Hearse, 1990). The rat has a high metabolic rate 
inversely correlated to body weight, and a consequently 
higher heart rate. This is reflected in more rapid enzymatic 
activities especially of the oxidative phosphorylation 
pathways in the myocardium, (Blank et al., 1989). The rat has 
a characteristic short ventricular action potential with an 
attenuated plateau, a high intracellular Na+ content, and an 
excitation-contraction coupling mechanism unusually dependent 
on ca 2+ {Galinanes and Hearse, 1990). 
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The susceptibility to a period of ischaemia is also different 
between species. The effectiveness of the different 
cardioplegic solutions may differ within a species, as well as 
between species. These differences were observed by Galifianes 
and Hearse ( 1990) who looked at the effect of cardioplegic 
arrest using the ST No 2 cardioplegic solution, on the 
recovery of hearts from different species of small animals, 
including the rat, guinea pig, rabbit and others. The guinea 
pig was found to be most susceptible to a period of ischaemia, 
while the rabbit was the least. The rat was intermediate 
between these extremes. Correlation of functional recovery 
with metabolite content was also species dependent. The use of 
a species which is vulnerable to ischaemia with a margin for 
impr9vement of recovery allows a safety factor when 
extrapolating to human patients. 
2) Size of heart 
Adequate distribution of the cardioplegic solution may to a 
large extent determine its efficacy. The ratio of perfusion to 
heart weight of the rat heart is 3 to 4 times that of the 
larger hearts, related to differences in metabolic rate 
(Bretschneider, 1980). The volume of cardioplegic solution 
flushed through the heart depends on the size of the heart. 
However, in larger hearts, there may be regions which are 
underperfused with each flush, which may then become necrotic 
over an extended period of arrest. 
The rat heart has a large surface to volume ratio, with 
smaller distances for diffusion, allowing considerably greater 
uptake of oxygen from the atmosphere in comparison to larger 
hearts. These differences may affect the relative recoveries 
of different species with different cardioplegic solutions. 
The size of the rat hearts also prevents the taking of biopsy 
samples for biochemical evaluations during and after the 
arrest period. 
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b) Isolated organ perfusions versus in vivo models 
1) Isolated heart perfusions 
Use of an isolated organ is associated with problems not found 
in vivo. When removing the heart, it may be damaged in some 
way. The heart is also not perfused for a short period before 
being cannulated. Factors including ischaemic preconditioning, 
usage of endogenous glycogen stores and areas of regional 
ischaemia may all affect heart function. It is difficult to 
control for these factors, and this results in a large 
variation in the function of the isolated perfused hearts. 
While exclusion criteria are used to discard hearts which do 
not initially perform within a normal range and each heart 
acts as its own control in the expression of the results, 
there is still a possible rundown in function over time in the 
isolated working heart, which may differ depending on initial 
function. While reperfused hearts are also discarded using 
exclusion criteria, there is still a large degree of 
variation, which may mask what is actually happening. The use 
of a model which more nearly replicates that of the clinical 
situation is recommended, such as in vivo recording of heart 
function. 
2) External factors 
Conditions in the laboratory, and in an isolated organ, can be 
much more easily controlled than in the theatre. The 
temperature of the myocardium can be kept much more constant, 
without interference from non-coronary collateral flow, and 
the difficulty in thermally isolating the in situ heart from 
the rest of the body. Temperature regulation in a donor heart 
is also difficult as hearts are normally immersed in a 
container of solution, which is then surrounded by ice. The 
temperature of the myocardium may fall to levels causing ice 
crystal formation, and subsequent injury to the cells. 
3) State of the heart 
The hearts used in the experiments are from young, heal thy 
animals. In cardio-pulmonary bypass, the hearts are in a 
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diseased or weakened state with different biochemical 
function. This may alter the effect of the solution. 
4) Perfusion - blood versus Krebs-Henseleit buffer 
Another variable which must be considered in the isolated 
organ model is the perfusate used. A crystalloid solution does 
not contain elements of blood such as neutrophils which may 
affect the degree of reperfusion injury of the hearts, as 
these are associated with a large free radical activity 
(Reimer et al., 1989). There are other components in the blood 
which also affect performance. In the isolated heart, the 
coronary flow is much higher than in vivo because of the 
absence of haemoglobin in the crystalloid solution. The oxygen 
content of the solution is less than that of oxygenated blood 
because of the lower oxygen carrying capacity. This results in 
a higher coronary flow in the isolated heart, and possibly 
reduces oxygen delivery to the myocardial cells. 
With a protein-free saline solution, water escapes from the 
vascular bed over time, leading to interstitial oedema. With 
an experiment of long duration, this may alter heart function 
significantly over time, leading to a bias in the functional 
recoveries of arrested hearts. Whole blood prevents oedema 
developing and decreases the interstitial space. 
Whole blood is difficult to use in an isolated perfusion 
system because of foaming, erythrocyte aggregations, clotting, 
protein precipitation, haemolysis and precipitation of 
erythrocyte ghosts. If blood is to be used, a model using a 
donor animal for perfusion of the heart, or an in vivo model, 
both with larger animals, is more advisable. 
5) Duration of experiments 
The time period allowed for recovery of the isolated organ is 
of necessity very short, in terms of minutes and hours, as 
there is rundown in function over time. The long term effects 
of heart preservation and subsequent recovery, in terms of 
days, cannot be adequately assessed. Post operative survival 
cannot be investigated. While the initial recoveries on 
reperfusion may be an indication of the efficacy of a 
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solution, the phenomenon of stunning is also present. While 
stunning may be regarded as deleterious to the patient, the 
heart may require a certain time period to recover from the 
ischaemic insult. The period of stunning may the ref ore be a 
protective mechanism, allowing conservation of energy in the 
initial reperfusion period. The clinical implications of 
stunning remain to be determined. The rate of recovery after 
cardioplegic arrest may differ with different solutions, but 
the absolute recovery may also differ. 
c) Determinants of heart function 
The aim of cardioplegia is to slow the rate of development of 
ischaemic injury. The extent of the injury can be assessed by 
measurement of contractile function, enzyme leakage, tissue 
metabolites, ultrastructure and electrophysiology. These show 
the directionality of injury, sometimes with a good 
correlation with recovery. 
However, the fun6tional indices and biochemical parameters 
used to determine recovery of heart function may also affect 
interpretation of results. The best possible index of function 
must be chosen to allow as accurate a reflection of recovery 
on reperfusion as possible to be made. This must be correlated 
with what is required in the clinical situation, where a good 
pressure may be needed although not at the expense of 
increased energy expenditure. Gal inanes and Hearse ( 19 9 O) in 
their study of the effects of ischaemia emphasised the use of 
the optimal index of function and metabolic recovery. Factors 
such as the bias in cardiac output due to the exaggerated 
coronary flow 1n the isolated organ perfused with a 
crystalloid solution as compared to sanguinous perfusion must 
be taken into account. 
The results of this study correspond with our findings. 
Al though there was some correlation of functional recovery 
with metabolic indices, the latter were not always indicative 
of the degree of recovery. Other indices of contractile heart 
function, as well as measurement of other biochemical 
variables, may give a more precise indication of the efficacy 
of the solution, and allow better extrapolation to the human 
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heart. The correlation of release of LDH during and after 
arrest is particularly indicative of a lack of correlation 
with recovery. Different factors led to differences in the 
amount of LDH washout, with little correspondence with the 
degree of recovery. These factors are discussed in the 
relevant sections of the results and discussions. As an 
absolute indicator of possible recovery, LDH could not be 
used. However, this index is a useful determinant of where 
injury may be occurring, and whether these effects have a 
large role to play in the recoveries of the hearts. 
d) Improvement of the model 
There are several models which have been used to test 
cardioplegic solutions. The isolated perfused rat heart model 
has many advantages including ease of procedure and enabling a 
large number of experiments to be done. There are several 
possible ways in.which the model can be improved and its use 
extended: 
1) Measurement of biochemical parameters including tissue ATP, 
CP and lactate could be made immediately after arrest, before 
reperfusion. This is a more sensitive indication of 
maintenance of high energy phosphates during arrest, and 
possibly of the degree of preservation engendered by the 
cardioplegic solution. 
2) More extensive biochemical studies can be made on the 
myocardial tissue to determine the effects of the cardioplegic 
solutions on various processes in the myocytes. This would 
give a more complete picture of the changes which occur. 
3) Electron micrograph studies can be made to determine 
changes to the myocardial structure with the cardioplegic 
solution. 
4) The use of diseased or compromised hearts may also affect 
the formulation of an optimal cardioplegic solution, as these 
hearts may undergo various alterations in their biochemical 
processes which alter their response to the solutions. Hearts 
from older animals, hypertensive or diabetic rats, and models 
with coronary ligation and various other interventions, can be 
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studied. These hearts may not recover as well as the normal 
healthy hearts, allowing room for more exploration of the 
effects of a cardioplegic solution. 
5) Reperfusion solutions can also be looked at with this 
model. Reperfusion injury is implicated as one of the major 
causes of damage associated with ischaemia and reperfusion. 
This is an important alternative to improving on the 
formulation of cardioplegic solutions as the best protection 
possible during arrest cannot necessarily prevent reperfusion 
injury. This may be especially important with the more long 
term preservation of donor hearts for transplantation. 
6) The use of blood as the perfusate before and after arrest 
may improve results as this alters the functioning of the 
hearts. However, this necessitates the use of a far more 
complicated model and the use of a rat which has a small heart 
is not necessarily possible. The use of larger animals is thus 
more advisable if blood is to be used. 
Larger animal models: 
1) The use of larger animals with correspondingly larger 
hearts facilitates experiments where more complex procedures 
are to be performed. This enables a model which more closely 
approximates the clinical situation to be used. An animal with 
a similar vasculature and general myocardial structure to that 
of the human is desirable. Such models including the baboon, 
dog, and pig have been used extensively in this field of 
research. However, the use of a slightly smaller animal such 
as the rabbit may also be used to obtain adequate answers. The 
use of this animal allows perfusion with blood, and in vivo 
model. 
2) The use of blood as the perfusate reduces many of the 
factors which are brought about by the use of an asanguinous 
perfusate. Blood may be used with a para-corporeal perfusion, 
where the heart is removed from the body but is still perfused 
by the animal. This allows good measurement of the functional 
parameters of the heart. An in vivo model with blood perfusion 
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is also good but the functional measurements obtained are not 
as accurate. 
3) An in vivo model allows more long term experiments to be 
performed, with recovery of the animal after arrest and 
reperfusion. The long term effects of the solution can then be 
studied. 
Other approaches which may be used include the use of cultures 
of the various cell populations, and investigation into the 
effects of the different solutions on the survival of these 
cells. The electrophysiological changes elicited can be 
studied using single cells. Measurement of changes in resting 
membrane potential and subsequent ca2+ fluxes across the 
sarcolemma can be made. 
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